1
|
Missirlian M, Firdaouss M, Richou M, Hernandez C, Gargiulo L, Bucalossi J, Brun C, Corre Y, Delmas E, Greuner H, Guillermin B, Gunn J, Hatchressian J, Jalageas R, Li Q, Lipa M, Lozano M, Luo G, Pocheau C, Roche H, Tsitrone E, Vignal N, Wang W, Saille A, Zago B. Manufacturing, testing and installation of the full tungsten actively cooled ITER-like divertor in the WEST tokamak. Fusion Engineering and Design 2023. [DOI: 10.1016/j.fusengdes.2023.113683] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/29/2023]
|
2
|
Romitti G, Liberos A, Romero P, Serra D, Garcia I, Lozano M, Sebastian R, Rodrigo M. Characterization of the Electrophysiological Characteristics of Chronic Atrial Fibrillation for Efficient Simulations. Annu Int Conf IEEE Eng Med Biol Soc 2023; 2023:1-4. [PMID: 38082841 DOI: 10.1109/embc40787.2023.10340415] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/18/2023]
Abstract
Atrial biophysical simulations have the potential to enhance outcomes by enabling the simulation of pharmacological and ablative strategies. However, the high computational times associated with such simulations render them unsuitable for diagnostic purposes. To address this challenge, discrete models such as cellular automata (CA) have been developed, which consider a finite number of states, thus significantly reducing computational times. Yet, there is a pressing need to determine whether CA can replicate pathological simulations with accuracy. The analysis of simulations under different degrees of electrical remodeling shows an expected increase of Action Potential Duration (APD) with the previous Diastolic Interval (DI) interval, indicating short-term memory of atrial cardiomyocytes: shorter APD0 provoked shorter APD+1, and previous DI has a similar effect on APD+1. Independent prediction using both APD0 and DI was found to provide a far better estimation of APD+1 values, compared to relying on DI alone (p<<0.01). Finally, the CA models were able to replicate reentrant patterns and cycle lengths of different states of atrial remodeling with a high degree of accuracy when compared to biophysical simulations. Overall, the use of atrial CA with short-term memory allows accurate reproduction of arrhythmic behavior in pathological tissue within a clinically relevant timeframe.Clinical Relevance- Discrete electrophysiological models simulate pathological self-sustained arrhythmias in diagnostic times.
Collapse
|
3
|
Serra D, Franco P, Romero P, Romitti G, Garcia-Fernandez I, Lozano M, Liberos A, Penela D, Berruezo A, Camara O, Rodrigo M, Sebastian R. Assessment of Risk for Ventricular Tachycardia based on Extensive Electrophysiology Simulations. Annu Int Conf IEEE Eng Med Biol Soc 2023; 2023:1-4. [PMID: 38083190 DOI: 10.1109/embc40787.2023.10340169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/18/2023]
Abstract
Patients that have suffered a myocardial infarction are at high risk of developing ventricular tachycardia. Patient stratification is often determined by characterization of the underlying myocardial substrate by cardiac imaging methods. In this study, we show that computer modeling of cardiac electrophysiology based on personalized fast 3D simulations can help to assess patient risk to arrhythmia. We perform a large simulation study on 21 patient digital twins and reproduce successfully the clinical outcomes. In addition, we provide the sites which are prone to sustain ventricular tachycardias, i.e, onset sites around the scar region, and validate if they colocalize with exit sites from slow conduction channels.Clinical relevance- Fast electrophysiological simulations can provide advanced patient stratification indices and predict arrhythmic susceptibility to suffer from ventricular tachycardia in patients that have suffered a myocardial infarction.
Collapse
|
4
|
Puig I, Gea M, Núñez F, Ispierto L, Grau-López L, Roure S, Lozano M, Lucente G, Vilas D. Dystonic head tremor secondary to neurocysticercosis. Neurologia 2023; 38:226-227. [PMID: 37059575 DOI: 10.1016/j.nrleng.2022.03.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2022] [Accepted: 03/20/2022] [Indexed: 04/16/2023] Open
Affiliation(s)
- I Puig
- Neurology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
| | - M Gea
- Neurology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
| | - F Núñez
- Radiology Service, Institut Diagnòstic per la Imatge (IDI), Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain
| | - L Ispierto
- Neurology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
| | - L Grau-López
- Neurology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
| | - S Roure
- Infectious Diseases Department, Fight Against AIDS Foundation (FLS), Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
| | - M Lozano
- Neurology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
| | - G Lucente
- Neurology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
| | - D Vilas
- Neurology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.
| |
Collapse
|
5
|
Alonso-Garrido M, Lozano M, Riffo-Campos AL, Font G, Vila-Donat P, Manyes L. Assessment of single-nucleotide variant discovery protocols in RNA-seq data from human cells exposed to mycotoxins. Toxicol Mech Methods 2023; 33:215-221. [PMID: 36016515 DOI: 10.1080/15376516.2022.2117673] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
Abstract
Food and feed contamination by nonlegislated mycotoxins beauvericin (BEA) and enniatin B (ENB) is a worldwide health concern in the present. The principal objective of this work is to assess some of the existing protocols to discover the single nucleotide variants (SNVs) in transcriptomic data obtained by RNA-seq from Jurkat cells in vitro samples individually exposed to BEA and ENB at three concentration levels (1.5, 3 and 5 µM). Moreover, previous transcriptomic results will be compared with new findings obtained using a different protocol. SNVs rs201003509 in BEA exposed cells and the rs36045790 in ENB were found in the differentially expressed genes in all doses compared to controls by means of the Genome Analysis Toolkit (GATK) Best Practices workflow. SNV-RNA-seq complementary pipeline did not show any SNV. Concerning gene expression, discrepant results were found for 1.5 µM BEA exposed cells compared with previous findings. However, 354 overlapped differentially expressed genes (DEGs) were identified in the three ENB concentrations used, with 147 matches with respect to the 245 DEGs found in the previous results. In conclusion, the two discovery SNVs protocols based on variant calling from RNA-seq used in this work displayed very different results and there were SNVs found manually not identified by any pipeline. Additionally, the new gene expression analysis reported comparable but non identical DEGs to the previous transcriptomic results obtained from these RNA-seq data.
Collapse
Affiliation(s)
- M Alonso-Garrido
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Burjassot, Spain
| | - M Lozano
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Burjassot, Spain.,Epidemiology and Environmental Health Joint Research Unit, FISABIO - Universitat Jaume I - Universitat de València, València, Spain
| | - A L Riffo-Campos
- Millennium Nucleus on Sociomedicine (SocioMed) and Vicerrectoría Académica, Universidad de La Frontera, Temuco, Chile.,Department of Computer Science, ETSE, University of Valencia, Valencia, Spain
| | - G Font
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Burjassot, Spain
| | - P Vila-Donat
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Burjassot, Spain
| | - L Manyes
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Burjassot, Spain
| |
Collapse
|
6
|
Jagannatham S, Lozano M, Brustman L. An Electronic Medical Record Intervention to Increase Early Screening Rates for Gestational Diabetes. Am J Perinatol 2023. [PMID: 35973794 DOI: 10.1055/a-1925-5750] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
OBJECTIVES Our objective was to implement an electronic medical record reminder to perform the early gestational diabetes mellitus (GDM) screening test and to evaluate if this intervention increased screening rates. STUDY DESIGN We performed a retrospective chart review of all deliveries at Mount Sinai West in January 2020 to determine the number of patients that met criteria for and actually underwent early GDM screening. A total of 314 patients had complete charts with pregnancy data. The following American College of Obstetricians and Gynecologists (ACOG)-defined risk factors were collected: body mass index greater than 25 (Asians greater than 23), history of GDM, history of macrosomia, hypertension (systolic >140 or diastolic >90), polycystic ovarian syndrome, hemoglobin A1c above 5.7, cardiovascular disease, and family history of diabetes. We used this data to advocate for and design an electronic medical record-based intervention to remind obstetric providers to complete the early glucose challenge test screening for eligible patients at the first prenatal visit. RESULTS Our investigation confirms there is a low adherence rate of 12% at our facility to ACOG's updated early GDM screening guidelines (12 out of 97 patients). Furthermore, nearly one-fifth (16 out of 85) of eligible patients who did not receive screening were eventually diagnosed with GDM by screening at 24 to 28 weeks. After implementing an electronic medical record reminder at the initial prenatal visit, screening rates more than doubled to 28% (33 out of 115 eligible patients). The most common diabetic risk factors were high-risk ethnic background, current hypertension, family history of diabetes, history of polycystic ovarian syndrome, and body mass index of 40 or greater. CONCLUSION Our data suggests that obstetricians could be missing an opportunity to improve maternal and neonatal outcomes by diagnosing GDM earlier in pregnancy, as recommended by ACOG. The adoption of an electronic medical record reminder seems to improve the rate of indicated early GDM screening. KEY POINTS · There is a low adherence rate of 16% to ACOG's updated early GDM screening guidelines.. · After implementing an electronic medical record alert at the initial prenatal visit, screening rates nearly doubled.. · Screening rates were higher at prenatal practices with resident physician involvement in patient care..
Collapse
Affiliation(s)
- Shobha Jagannatham
- Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai West, New York City, New York
| | - Melissa Lozano
- Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai West, New York City, New York
| | - Lois Brustman
- Department of Obstetrics, Gynecology, and Reproductive Science, Department of Maternal Fetal Medicine, Icahn School of Medicine at Mount Sinai West, New York City, New York
| |
Collapse
|
7
|
Argüelles A, Viña I, Vigón P, Lozano M, Viña J. Study of the fatigue delamination behaviour of adhesive joints in carbon fibre reinforced epoxy composites, influence of the period of exposure to saline environment. Sci Rep 2022; 12:19789. [PMID: 36396728 PMCID: PMC9671895 DOI: 10.1038/s41598-022-23378-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2022] [Accepted: 10/31/2022] [Indexed: 11/18/2022] Open
Abstract
This work analyses the fatigue delamination and fracture stress behaviour under mode I of adhesive joints made on an epoxy matrix composite material with unidirectional carbon fibre reinforcement and a commercial epoxy-based adhesive. DCB type tests (for mode I) were used with the aim to quantify the influence of the period of exposure to a degradation process in a salt spray chamber, to which the tested samples were subjected, on their fatigue behaviour. For this purpose and after a previous static characterisation of the material in which the critical values of the energy release rate for different exposure periods were determined, the levels of the energy release rate to be applied in the fatigue tests and the exposure periods to be considered (no exposure, exposure during one week and twelve weeks) and a ratio of fatigue stress levels of R = Gmin/Gmax = 0.1 were defined. From this experimental data, the G-N fatigue initiation curves and the G-da/dN growth curves were obtained. The experimental data obtained, in the fatigue initiation phase of the delamination process, have been treated by means of a probabilistic model based on a Weibull distribution, the application of models of these characteristics has allowed a better interpretation of the experimental results obtained. The most relevant result of the work is that, in general, the fatigue limits obtained for the adhesive joint, under mode I fracture, when subjected to a degradation process in a saline environment, do not translate into a relevant loss of its resistance capacity against this fatigue delamination phenomenon, in its initiation phase. On the other hand, the crack growth rates of the material subjected to different periods of exposure to a saline environment are similar and higher than those obtained for the material without exposure.
Collapse
Affiliation(s)
- A. Argüelles
- grid.10863.3c0000 0001 2164 6351Department of Construction and Manufacturing Engineering, University of Oviedo, Edificio Departamental Oeste N°7, Campus de Viesques, 33203 Gijón, Spain
| | - I. Viña
- grid.10863.3c0000 0001 2164 6351Department of Construction and Manufacturing Engineering, University of Oviedo, Edificio Departamental Oeste N°7, Campus de Viesques, 33203 Gijón, Spain
| | - P. Vigón
- grid.10863.3c0000 0001 2164 6351Department of Construction and Manufacturing Engineering, University of Oviedo, Edificio Departamental Oeste N°7, Campus de Viesques, 33203 Gijón, Spain
| | - M. Lozano
- grid.10863.3c0000 0001 2164 6351Department of Construction and Manufacturing Engineering, University of Oviedo, Edificio Departamental Oeste N°7, Campus de Viesques, 33203 Gijón, Spain
| | - J. Viña
- grid.10863.3c0000 0001 2164 6351Department of Materials Science and Metallurgical Engineering, University of Oviedo, Edificio Departamental Este, Campus de Viesques, 33203 Gijón, Spain
| |
Collapse
|
8
|
Cimbalo A, Frangiamone M, Lozano M, Escrivá L, Vila-Donat P, Manyes L. Protective role of fermented whey and pumpkin extract against aflatoxin B 1 and ochratoxin A toxicity in Jurkat T-cells. WORLD MYCOTOXIN J 2022. [DOI: 10.3920/wmj2022.2780] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
The beneficial effect of fermented whey and pumpkin extract rich in carotenoids was evaluated in Jurkat cells against aflatoxin B1 (AFB1) and ochratoxin A (OTA) cytotoxicity through a proteomic approach. The functional ingredients were added into mycotoxin contaminated bread formulation, which were digested in vitro in order to simulate human intestinal absorption. Cell cultures were exposed during 7 days to these mycotoxins dissolved in: (a) 0.1% organic solvent (DMSO), (b) an intestinal digest of bread with pumpkin individually (PID) and (c) an intestinal digest of bread with pumpkin mixed with fermented whey (PID+WF). Extracted proteins were subjected to reduction and alkylation and subsequently a tryptic digestion in order to be analysed by liquid chromatography coupled with quadrupole time of flight (LC/MS-Q-TOF). Results obtained highlighted the beneficial role of functional ingredients employed through the identification of proteins involved in several biological processes and metabolic pathways, mainly antioxidant activity, nucleosome assembly and secretory senescence phenotype. Among proteins involved in antioxidant activity, peroxiredoxin 1 and 2 stand out. Comparing the different conditions investigated, a remarkable change was observed in their expression, ranging from a repression using the standard (DMSO 0.1%), to an overexpression when treated with the functional ingredients. Similarly, after PID and PID+WF treatment, histones’ expression implicated in the metabolic pathway of nucleosome assembly, such as H2A, H2B, H2C, H3 and H4, was increased. Furthermore, the expression of protein cyclin A2, which downregulation is involved in limiting carcinogenic cells growth, was lower in presence of both functional ingredients. Based on these findings, functional ingredients can act as protectors against genomic stress caused by mycotoxins, preventing the loss of vital cell functions and paralysing the growth of carcinogenic cells.
Collapse
Affiliation(s)
- A. Cimbalo
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Av. Vicent Andrés Estellés s/n., 46100 Burjassot, Spain
| | - M. Frangiamone
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Av. Vicent Andrés Estellés s/n., 46100 Burjassot, Spain
| | - M. Lozano
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Av. Vicent Andrés Estellés s/n., 46100 Burjassot, Spain
| | - L. Escrivá
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Av. Vicent Andrés Estellés s/n., 46100 Burjassot, Spain
| | - P. Vila-Donat
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Av. Vicent Andrés Estellés s/n., 46100 Burjassot, Spain
| | - L. Manyes
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Av. Vicent Andrés Estellés s/n., 46100 Burjassot, Spain
| |
Collapse
|
9
|
Escrivá L, Manyes L, Vila-Donat P, Font G, Meca G, Lozano M. Bioaccessibility and bioavailability of bioactive compounds from yellow mustard flour and milk whey fermented with lactic acid bacteria. Food Funct 2021; 12:11250-11261. [PMID: 34708849 DOI: 10.1039/d1fo02059e] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Microbial fermentation with lactic acid bacteria (LAB) is a natural food biopreservation method. Yellow mustard and milk whey are optimum substrates for LAB fermentation. The aim of the present study was to evaluate the bioaccessibility and bioavailability of bioactive compounds from yellow mustard flour and milk whey both with and without LAB fermentation. All extracts were subjected to a simulated digestion process. Total polyphenols, DL-3-phenyllactic acid (PLA), lactic acid, and the antioxidant activity were determined in the studied matrices before and after simulated digestion. Yellow mustard flour was significantly richer in total polyphenols, whereas significantly higher concentrations of PLA and lactic acid were observed in milk whey. Similar antioxidant activity was determined in both ingredients being in all cases strongly reduced after in vitro digestion. Higher bioaccessibility was found for polyphenols and PLA in milk whey. Transepithelial transport of total polyphenols was higher in yellow mustard flour compared to milk whey, reaching bioavailability values between 3-7% and 1-2%, respectively. PLA transepithelial transport was only significant in both fermented matrices with bioavailability around 4-6%. Transepithelial transport of lactic acid reached values of 31-34% (bioavailability ∼ 22%) and 15-78% (bioavailability ∼ 3%) in milk whey and yellow mustard flour, respectively. LAB fermentation showed beneficial effects on enriching extracts with PLA, lactic acid, and antioxidant activity, as well as increasing bioaccessibility of these acids in yellow mustard flour and total polyphenol bioavailability in milk whey. Results pointed to yellow mustard flour and milk whey as natural preservative ingredients used in the food industry, especially when fermented with LAB.
Collapse
Affiliation(s)
- L Escrivá
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Av/Vicent A. Estellés, s/n 46100 Burjassot, València, Spain.
| | - L Manyes
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Av/Vicent A. Estellés, s/n 46100 Burjassot, València, Spain.
| | - P Vila-Donat
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Av/Vicent A. Estellés, s/n 46100 Burjassot, València, Spain.
| | - G Font
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Av/Vicent A. Estellés, s/n 46100 Burjassot, València, Spain.
| | - G Meca
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Av/Vicent A. Estellés, s/n 46100 Burjassot, València, Spain.
| | - M Lozano
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Av/Vicent A. Estellés, s/n 46100 Burjassot, València, Spain.
| |
Collapse
|
10
|
Escriba C, Alambiaga A, Benavent M, Miret C, Garcia A, Lozano M, Gonzalez D, Crespo J, Teruel J. P–532 Embryo quality needs to be considered as a main criterion when selecting mosaic embryos for transfer. Hum Reprod 2021. [DOI: 10.1093/humrep/deab130.531] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Study question
Should we consider embryo quality as one of the most important criteria to follow when transferring a mosaic embryo?
Summary answer
Embryo quality is an implantation biomarker both for euploid and mosaic embryos, and also a determinant for selecting the most eligible mosaic for transfer.
What is known already
Several studies show the benefit of transferring mosaic embryos when there are no euploid embryos to transfer, and they still result in ongoing pregnancies and what is more important is that they result in healthy babies.
Studies and guidelines suggest prioritizing mosaic embryos based on maternal age, chromosomes impacted, percentage of aneuploidy, number of chromosomes involved, type of mosaic (simple vs complex, segmental vs complete, monosomy vs trisomy) but embryo quality is never part of these criteria.
Studies claim that mosaic implantation rate is lower than euploid embryos, but they never show if both populations are comparable in terms of quality.
Study design, size, duration
This is a retrospective observational study performed in a private centre between February 2018 and January 2020. The study includes the data analysis of 96 euploid blastocysts and 14 low risk mosaic blastocysts (defining low risk regarding chromosome syndromes and less than 50% level mosaicism). All transferred in single embryo transfer (SET) to 105 patients after PGT-A (mean maternal age 38,9 years).
The SET factor enables us to track the implantation outcome of all embryos.
Participants/materials, setting, methods
PGT-A with NGS technology was offered to patients of advanced maternal age and/or with repeated IVF failures. Trophectoderm biopsies were performed on day 5 and/or day 6 embryos, with laser assistance. Blastocyst morphology was scored in 3 groups: A: excellent (AA, AB, BA), B: good (BB), C: average and poor-quality embryos (BC, CB, CC). (Gardner-Schoolcraft classification)
Low risk mosaic embryo transfer was offered to patients with no euploid embryos to transfer.
Main results and the role of chance
We found no significant differences between both populations (euploid and mosaic embryos) in terms of embryo quality (Chi^2 p-value =0,0975) so we were able to compare the overall implantation of similar quality populations.
Despite euploid implantation being higher as described in most studies, no statistical differences (Chi^2 p-value = 0,4344) were found in terms of implantation rates between mosaic (57,0%) and euploid (67,6%) blastocysts during the same period. There are no differences between the mean age of both groups (39,7 vs 38,8 years, respectively).
The implantation rates for euploid blastocysts were 79,5% (n = 39), 62,7% (n = 51) and 33,3% (n = 6) in the A, B and C blastocyst quality groups, respectively, showing significative differences among the three groups.
The implantation rates of low-risk mosaic blastocysts were 100% (n = 3), 62,5% (n = 8) and 0,0% (n = 3) in the A, B and C blastocyst morphology groups, respectively, showing also still significant differences among the three groups despite the small population. (Chi^2 p-values according to implantation: Euploid =0,0434; Mosaic=0,0419)
We have also compared the three quality categories between both populations showing no significative differences (Chi^2 p-values according to quality: A = 0,4344; B = 0,9894; C = 0,2568), concluding that same quality embryos behave the same way despite being euploid or mosaic.
Limitations, reasons for caution
The study is limited by its retrospective nature and the low number of mosaic embryos transferred as they are the last option for transfer. Additionally, it is common to transfer more than one mosaic embryo to increase the chances of pregnancy, therefore losing implantation track.
Wider implications of the findings: Embryo quality has always been a strong biomarker predictable for implantation and this is also true for mosaic embryos as well. It is a simple concept, but we cannot compare implantation potential of euploid embryos with mosaic embryos without describing both populations in terms of quality.
Trial registration number
Not applicable
Collapse
Affiliation(s)
- C Escriba
- Equipo Medico Crespo, IVF lab, Valencia, Spain
| | - A Alambiaga
- Equipo Medico Crespo, Genetics, Valencia, Spain
| | - M Benavent
- Equipo Medico Crespo, IVF lab, Valencia, Spain
| | - C Miret
- Equipo Medico Crespo, IVF lab, Valencia, Spain
| | - A Garcia
- Equipo Medico Crespo, IVF lab, Valencia, Spain
| | - M Lozano
- Equipo Medico Crespo, IVF lab, Valencia, Spain
| | - D Gonzalez
- Equipo Medico Crespo, IVF lab, Valencia, Spain
| | - J Crespo
- Equipo Medico Crespo, medical director, Valencia, Spain
| | - J Teruel
- Equipo Medico Crespo, IVF lab, Valencia, Spain
| |
Collapse
|
11
|
Cimbalo A, Frangiamone M, Juan C, Font G, Lozano M, Manyes L. Proteomics evaluation of enniatins acute toxicity in rat liver. Food Chem Toxicol 2021; 151:112130. [PMID: 33741480 DOI: 10.1016/j.fct.2021.112130] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2021] [Revised: 03/08/2021] [Accepted: 03/10/2021] [Indexed: 12/12/2022]
Abstract
Enniatins (ENs) are emerging mycotoxins produced by Fusarium fungi which are cytotoxic also at low concentrations due to its ionophoric properties. The aim of this study was to evaluate the hepatic toxicity of ENs exposure at different concentrations in Wistar rats through a proteomic approach. Animals were intoxicated by oral gavage with medium (EN A 256, ENA1 353, ENB 540, ENB1 296 μg/mL) and high concentrations (ENA 513, ENA1 706, ENB 1021, ENB1 593 μg/mL) of an ENs mixture and sacrificed after 8 h. Protein extraction was performed using powdered liver. Peptides were analyzed using a liquid chromatography coupled with a quadrupole time-of-flight mass spectrometer. Proteins were filtered by abundance using Mass Professional Profiler software (Agilent Technologies) and 57 were differentially expressed when compared to the control. In terms of abundance, the liver biomarker Carboamoyl-phosphate synthase showed the highest levels in all conditions employed while actin-1 had the lowest. Bioinformatic analysis using DAVID platform reported acetylation, nucleotide phosphate-binding region:NAD and catalytic activity as the most represented terms. Furthermore, metabolism was the most significant and enriched pathway in Reactome overrepresentation. In conclusion, ENs acute exposure caused protein expression changes related to major cellular processes in rats, hinting its involvement in liver disturbance.
Collapse
Affiliation(s)
- A Cimbalo
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, Universitat de València, Carrer Vicent Andrés Estellés s/n, 46100, Bujassot, Spain
| | - M Frangiamone
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, Universitat de València, Carrer Vicent Andrés Estellés s/n, 46100, Bujassot, Spain
| | - C Juan
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, Universitat de València, Carrer Vicent Andrés Estellés s/n, 46100, Bujassot, Spain
| | - G Font
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, Universitat de València, Carrer Vicent Andrés Estellés s/n, 46100, Bujassot, Spain
| | - M Lozano
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, Universitat de València, Carrer Vicent Andrés Estellés s/n, 46100, Bujassot, Spain.
| | - L Manyes
- Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, Universitat de València, Carrer Vicent Andrés Estellés s/n, 46100, Bujassot, Spain
| |
Collapse
|
12
|
Brand A, De Angelis V, Vuk T, Garraud O, Lozano M, Politis D. Review of indications for immunoglobulin (IG) use: Narrowing the gap between supply and demand. Transfus Clin Biol 2021; 28:96-122. [DOI: 10.1016/j.tracli.2020.12.005] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
|
13
|
Puig I, Alvarez M, Lozano M, Lucente G. A case of late-onset osmotic demyelination syndrome. Neurologia 2020; 36:S0213-4853(20)30311-X. [PMID: 33176921 DOI: 10.1016/j.nrl.2020.10.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2020] [Accepted: 10/10/2020] [Indexed: 10/23/2022] Open
Affiliation(s)
- I Puig
- Department of Neuroscience, Hospital Germans Trias i Pujol, Badalona, Barcelona, España
| | - M Alvarez
- Department of Neuroscience, Hospital Germans Trias i Pujol, Badalona, Barcelona, España
| | - M Lozano
- Department of Neuroscience, Hospital Germans Trias i Pujol, Badalona, Barcelona, España
| | - G Lucente
- Department of Neuroscience, Hospital Germans Trias i Pujol, Badalona, Barcelona, España; Grup de Recerca en Malalties Neuromusculars i Neuropediatriques, Department of Neurosciences, Institut Investigació en Ciències de la Salut Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, España; Universitat Autonoma de Barcelona, Badalona, Barcelona, España.
| |
Collapse
|
14
|
Borderias T, Gonzalez Lizarbe S, Sanchez J, De Tapia B, Catoya S, Cabrera I, Molina M, Lozano M, Lujan E, Canteli A, Castrillo C, Ruiz Lera M, Sarralde J, Cobo M, Burgos V. Is primary graft failure still a challenge in time of venoarterial extracorporeal membrane oxygenation? Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Primary graft failure (PGF) is the leading cause of early mortality after heart transplantation (HT). Its increasing incidence during the last decade may be triggered by the disbalance between receptors and donors that forces the acceptance of suboptimal organs.
Purpose
The aim of our work was to analyse the mechanical circulatory support (MCS) with VA-ECMO in refractory to inotropes PGF and determinate its impact in terms of graft function recovery and survival.
Methods
A retrospective study, analyzing our database of circulatory assist devices between 2009 and 2019. During this period, 252 devices have been implanted (154 ECMOs and 98 ventricular assist devices) and 201 patients have received a HT. We describe the characteristics and evolution of all PGF cases managed with VA-ECMO.
Results
Thirty nine patients (19.4%) developed PGF, defined as significant left, right or biventricular systolic dysfunction in the first 24 hours after HT, associated with hemodynamic instability and requiring high dose of inotropes, intra-aortic balloon pump (IABP) or VA-ECMO. Twenty two cases (56.4%) underwent a VA-ECMO implantation by peripheral cannulation as a bridge to recovery.
The median age was 50.8 (44.3–57.3) years and 77% were male. Biventricular dysfunction was observed in 50% and isolated right ventricular dysfunction in the remaining 50%. At the time of implantation, 59% had IABP and the median of inotropic score was 24 (8–40). Two complications occurred during implantation (one because of a complex vascular access and one due to a malposition of the venous cannula). Anticoagulation was started after a median of 19 hours (10–28; 59% sodic heparin and 36% bivalirudin).
The median support duration was 6.2 days (3–9.2). Graft function was recovered in 90%, making it possible to withdraw the device successfully in 82% of patients. The remaining 18% deceased during the support (2 because of multiorgan failure and 2 due to absence of function recovery).The median hospital length of stay was 63 days (33–93) and hospital and 1-year survival was 68.1%.
Conclusion
The support with VA-ECMO allowed graft function recovery in 90% of severe PGF cases, with a similar survival rate to other centres with MCS. In a scenario with a mortality rate superior to 50%, the MCS programs have managed to increase survival, avoid retransplantation in times of donor shortage and handle the use of suboptimal donors with better chances of success.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- T Borderias
- University Hospital Marques de Valdecilla, Santander, Spain
| | | | - J Sanchez
- University Hospital Marques de Valdecilla, Santander, Spain
| | - B De Tapia
- University Hospital Marques de Valdecilla, Santander, Spain
| | - S Catoya
- University Hospital Marques de Valdecilla, Santander, Spain
| | - I Cabrera
- University Hospital Marques de Valdecilla, Santander, Spain
| | - M Molina
- University Hospital Marques de Valdecilla, Santander, Spain
| | - M Lozano
- University Hospital Marques de Valdecilla, Santander, Spain
| | - E Lujan
- University Hospital Marques de Valdecilla, Santander, Spain
| | - A Canteli
- University Hospital Marques de Valdecilla, Santander, Spain
| | - C Castrillo
- University Hospital Marques de Valdecilla, Santander, Spain
| | - M Ruiz Lera
- University Hospital Marques de Valdecilla, Santander, Spain
| | - J.A Sarralde
- University Hospital Marques de Valdecilla, Santander, Spain
| | - M Cobo
- University Hospital Marques de Valdecilla, Santander, Spain
| | - V Burgos
- University Hospital Marques de Valdecilla, Santander, Spain
| |
Collapse
|
15
|
Butler PA, Gaffney LP, Spagnoletti P, Konki J, Scheck M, Smith JF, Abrahams K, Bowry M, Cederkäll J, Chupp T, de Angelis G, De Witte H, Garrett PE, Goldkuhle A, Henrich C, Illana A, Johnston K, Joss DT, Keatings JM, Kelly NA, Komorowska M, Kröll T, Lozano M, Singh BSN, O'Donnell D, Ojala J, Page RD, Pedersen LG, Raison C, Reiter P, Rodriguez JA, Rosiak D, Rothe S, Shneidman TM, Siebeck B, Seidlitz M, Sinclair J, Stryjczyk M, Van Duppen P, Vinals S, Virtanen V, Warr N, Wrzosek-Lipska K, Zielinska M. Publisher Correction: The observation of vibrating pear-shapes in radon nuclei. Nat Commun 2020; 11:5185. [PMID: 33037232 PMCID: PMC7547707 DOI: 10.1038/s41467-020-19081-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Affiliation(s)
- P A Butler
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK.
| | - L P Gaffney
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK.,CERN, Geneva, 23 CH-1211, Switzerland
| | - P Spagnoletti
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - J Konki
- CERN, Geneva, 23 CH-1211, Switzerland
| | - M Scheck
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - J F Smith
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - K Abrahams
- Department of Physics & Astronomy, University of the Western Cape, Private Bag X17, Bellville, 7535, South Africa
| | - M Bowry
- TRIUMF, Vancouver, V6T 2A3, BC, Canada
| | - J Cederkäll
- Physics Department, Lund University, Box 118, Lund, SE-221 00, Sweden
| | - T Chupp
- Department of Physics, University of Michigan, Ann Arbor, 48104 MI, USA
| | - G de Angelis
- INFN Laboratori Nazionali di Legnaro, Legnaro, 35020 PD, Italy
| | - H De Witte
- Instituut voor Kern- en Stralingsfysica, KU Leuven, Leuven, B-3001, Belgium
| | - P E Garrett
- Department of Physics, University of Guelph, Guelph, N1G 2W1, Ontario, Canada
| | - A Goldkuhle
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - C Henrich
- Institut für Kernphysik, Technische Universität Darmstadt, Darmstadt, 64289, Germany
| | - A Illana
- INFN Laboratori Nazionali di Legnaro, Legnaro, 35020 PD, Italy
| | | | - D T Joss
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK
| | - J M Keatings
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - N A Kelly
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - M Komorowska
- Heavy Ion Laboratory, University of Warsaw, Warsaw, PL-02-093, Poland
| | - T Kröll
- Institut für Kernphysik, Technische Universität Darmstadt, Darmstadt, 64289, Germany
| | - M Lozano
- CERN, Geneva, 23 CH-1211, Switzerland
| | - B S Nara Singh
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - D O'Donnell
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - J Ojala
- Department of Physics, University of Jyvaskyla, P.O. Box 35, Jyvaskyla, FIN-40014, Finland.,Helsinki Institute of Physics, P.O. Box 64, Helsinki, FIN-00014, Finland
| | - R D Page
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK
| | - L G Pedersen
- Department of Physics, University of Oslo, P.O. Box 1048, Oslo, N-0316, Norway
| | - C Raison
- Department of Physics, University of York, York, YO10 5DD, UK
| | - P Reiter
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | | | - D Rosiak
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - S Rothe
- CERN, Geneva, 23 CH-1211, Switzerland
| | | | - B Siebeck
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - M Seidlitz
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - J Sinclair
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - M Stryjczyk
- Instituut voor Kern- en Stralingsfysica, KU Leuven, Leuven, B-3001, Belgium
| | - P Van Duppen
- Instituut voor Kern- en Stralingsfysica, KU Leuven, Leuven, B-3001, Belgium
| | - S Vinals
- Consejo Superior De Investigaciones Científicas, Madrid, S 28040, Spain
| | - V Virtanen
- Department of Physics, University of Jyvaskyla, P.O. Box 35, Jyvaskyla, FIN-40014, Finland.,Helsinki Institute of Physics, P.O. Box 64, Helsinki, FIN-00014, Finland
| | - N Warr
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - K Wrzosek-Lipska
- Heavy Ion Laboratory, University of Warsaw, Warsaw, PL-02-093, Poland
| | - M Zielinska
- IRFU CEA, Université Paris-Saclay, Gif-sur-Yvette, F-91191, France
| |
Collapse
|
16
|
Garraud O, Vuk T, Lozano M, Tissot JD. Transfusion medicine: Overtime paradigm changes and emerging paradoxes. Transfus Clin Biol 2020; 27:262-267. [PMID: 33035654 PMCID: PMC7537623 DOI: 10.1016/j.tracli.2020.10.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
This essay aims to discuss some aspects of blood transfusion in the perspective of the changes that occurred over time as well as modifications of the paradigms that transformed the activities and the organization of blood transfusion services. Without specific knowledge, pioneers envisioned precision and personalized medicine, rendering transfusion medicine operational. Transfusion medicine is like The Picture of Dorian Grey: always young despite being old and sometimes appearing old-fashioned. Over the years, the transfusion medicine discipline has evolved, and major progress has been achieved, despite some troublesome periods (for example, the tainted blood scandal, and—at the time being—the offending plasma market and the selling of human parts). Transfusion medicine has at all times implemented the rapidly developing biomedical technologies to secure blood components. The safety of blood components has now reached an exceptional level in economically wealthy countries, especially compared to other health care disciplines. Strengthening of the safety has mandated that blood donors and recipients are unrelated, an issue which has eased preservation and fractionation practices; blood is no longer arm-to-arm transfused and neither is whole blood, the commonest component. However, it is interesting to note that a revival is occurring as whole blood is back on stage for certain specific indications, which is one among the many paradoxes encountered while studying this discipline.
Collapse
Affiliation(s)
- O Garraud
- Université de Lyon Saint-Étienne, 10, rue Tréfilerie, 42023 Saint-Etienne Cedex 2, France; Institut National de la Transfusion Sanguine, 6, rue Alexandre Cabanel, 75015 Paris, France.
| | - T Vuk
- Croatian institute of transfusion medicine, Petrova ul. 3, 10000 Zagreb, Croatia
| | - M Lozano
- Clinic university hospital Barcelona, university of Barcelona, 170C. de Villarroel, 08036 Barcelona, Spain
| | - J-D Tissot
- Faculté de biologie et de médecine, université de Lausanne, 21, rue du Bugnon, 1011 Lausanne, Switzerland
| |
Collapse
|
17
|
Porta R, Serrano P, Paltrinieri A, Ristic G, Canals C, Lozano M. Neonatal alloimmune thrombocytopenia due to anti-HPA 5a in a HPA-5a homozygous neonate. Transfus Apher Sci 2020; 59:102880. [PMID: 32763115 DOI: 10.1016/j.transci.2020.102880] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2020] [Revised: 07/17/2020] [Accepted: 07/17/2020] [Indexed: 10/23/2022]
Abstract
The most frequently involved antigen in severe fetal and neonatal alloimmune thrombocytopenia (FNAIT) is the human platelet antigen 1a. Cases of FNAIT caused by HPA-5a antigen are extremely rare, and usually not severe. We report a case of FNAIT caused by anti-HPA antibodies directed to the HPA-5a antigen. The thrombocytopenia was moderate with a minimal platelet count of 36 × 109/L by day 3, and spontaneously resolved by day 10. The pregnancy had been obtained by in vitro fertilization using embryo donation, creating a complete genetic disparity between the HPA 5b5b mother and the HPA 5a5a homozygous neonate. The use of ART with gamete donation can increase the risk and the severity of alloimmune thrombocytopenia and must be considered in new and subsequent pregnancies.
Collapse
Affiliation(s)
- R Porta
- Hospital Dexeus, Pediatrics-Neonatology, Barcelona, Catalonia, Spain.
| | - P Serrano
- Hospital Dexeus, Pediatrics-Neonatology, Barcelona, Catalonia, Spain
| | - A Paltrinieri
- Hospital Dexeus, Pediatrics-Neonatology, Barcelona, Catalonia, Spain
| | - G Ristic
- Hospital Dexeus, Pediatrics-Neonatology, Barcelona, Catalonia, Spain
| | - C Canals
- Immunohematology Laboratory. Banc de Sang i Teixits. Barcelona, Catalonia, Spain
| | - M Lozano
- Hospital Dexeus, Transfusion Department, Barcelona, Catalonia, Spain
| |
Collapse
|
18
|
Butler PA, Gaffney LP, Spagnoletti P, Konki J, Scheck M, Smith JF, Abrahams K, Bowry M, Cederkäll J, Chupp T, de Angelis G, De Witte H, Garrett PE, Goldkuhle A, Henrich C, Illana A, Johnston K, Joss DT, Keatings JM, Kelly NA, Komorowska M, Kröll T, Lozano M, Singh BSN, O'Donnell D, Ojala J, Page RD, Pedersen LG, Raison C, Reiter P, Rodriguez JA, Rosiak D, Rothe S, Shneidman TM, Siebeck B, Seidlitz M, Sinclair J, Stryjczyk M, Van Duppen P, Vinals S, Virtanen V, Warr N, Wrzosek-Lipska K, Zielinska M. Addendum: The observation of vibrating pear-shapes in radon nuclei. Nat Commun 2020; 11:3560. [PMID: 32661232 PMCID: PMC7359340 DOI: 10.1038/s41467-020-17309-y] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Affiliation(s)
- P A Butler
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK.
| | - L P Gaffney
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK.,CERN, Geneva, 23 CH-1211, Switzerland
| | - P Spagnoletti
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - J Konki
- CERN, Geneva, 23 CH-1211, Switzerland
| | - M Scheck
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - J F Smith
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - K Abrahams
- Department of Physics & Astronomy, University of the Western Cape, Private Bag X17, Bellville, 7535, South Africa
| | - M Bowry
- TRIUMF, Vancouver, V6T 2A3, BC, Canada
| | - J Cederkäll
- Physics Department, Lund University, Box 118, Lund, SE-221 00, Sweden
| | - T Chupp
- Department of Physics, University of Michigan, Ann Arbor, 48104, MI, USA
| | - G de Angelis
- INFN Laboratori Nazionali di Legnaro, Legnaro, 35020 PD, Italy
| | - H De Witte
- Instituut voor Kern- en Stralingsfysica, KU Leuven, Leuven, B-3001, Belgium
| | - P E Garrett
- Department of Physics, University of Guelph, Guelph, N1G 2W1, Ontario, Canada
| | - A Goldkuhle
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - C Henrich
- Institut für Kernphysik, Technische Universität Darmstadt, Darmstadt, 64289, Germany
| | - A Illana
- INFN Laboratori Nazionali di Legnaro, Legnaro, 35020 PD, Italy
| | | | - D T Joss
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK
| | - J M Keatings
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - N A Kelly
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - M Komorowska
- Heavy Ion Laboratory, University of Warsaw, Warsaw, PL-02-093, Poland
| | - T Kröll
- Institut für Kernphysik, Technische Universität Darmstadt, Darmstadt, 64289, Germany
| | - M Lozano
- CERN, Geneva, 23 CH-1211, Switzerland
| | - B S Nara Singh
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - D O'Donnell
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - J Ojala
- Department of Physics, University of Jyvaskyla, P.O. Box 35, Jyvaskyla, FIN-40014, Finland.,Helsinki Institute of Physics, P.O. Box 64, Helsinki, FIN-00014, Finland
| | - R D Page
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK
| | - L G Pedersen
- Department of Physics, University of Oslo, P.O. Box 1048, Oslo, N-0316, Norway
| | - C Raison
- Department of Physics, University of York, York, YO10 5DD, UK
| | - P Reiter
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | | | - D Rosiak
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - S Rothe
- CERN, Geneva, 23 CH-1211, Switzerland
| | | | - B Siebeck
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - M Seidlitz
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - J Sinclair
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - M Stryjczyk
- Instituut voor Kern- en Stralingsfysica, KU Leuven, Leuven, B-3001, Belgium
| | - P Van Duppen
- Instituut voor Kern- en Stralingsfysica, KU Leuven, Leuven, B-3001, Belgium
| | - S Vinals
- Consejo Superior De Investigaciones Científicas, Madrid, S 28040, Spain
| | - V Virtanen
- Department of Physics, University of Jyvaskyla, P.O. Box 35, Jyvaskyla, FIN-40014, Finland.,Helsinki Institute of Physics, P.O. Box 64, Helsinki, FIN-00014, Finland
| | - N Warr
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - K Wrzosek-Lipska
- Heavy Ion Laboratory, University of Warsaw, Warsaw, PL-02-093, Poland
| | - M Zielinska
- IRFU CEA, Université Paris-Saclay, Gif-sur-Yvette, F-91191, France
| |
Collapse
|
19
|
Rosenthal VD, Bat-Erdene I, Gupta D, Belkebir S, Rajhans P, Zand F, Myatra SN, Afeef M, Tanzi VL, Muralidharan S, Gurskis V, Al-Abdely HM, El-Kholy A, AlKhawaja SAA, Sen S, Mehta Y, Rai V, Hung NV, Sayed AF, Guerrero-Toapanta FM, Elahi N, Morfin-Otero MDR, Somabutr S, De-Carvalho BM, Magdarao MS, Velinova VA, Quesada-Mora AM, Anguseva T, Ikram A, Aguilar-de-Moros D, Duszynska W, Mejia N, Horhat FG, Belskiy V, Mioljevic V, Di-Silvestre G, Furova K, Gamar-Elanbya MO, Gupta U, Abidi K, Raka L, Guo X, Luque-Torres MT, Jayatilleke K, Ben-Jaballah N, Gikas A, Sandoval-Castillo HR, Trotter A, Valderrama-Beltrán SL, Leblebicioglu H, Riera F, López M, Maurizi D, Desse J, Pérez I, Silva G, Chaparro G, Golschmid D, Cabrera R, Montanini A, Bianchi A, Vimercati J, Rodríguez-del-Valle M, Domínguez C, Saul P, Chediack V, Piastrelini M, Cardena L, Ramasco L, Olivieri M, Gallardo P, Juarez P, Brito M, Botta P, Alvarez G, Benchetrit G, Caridi M, Stagnaro J, Bourlot I, García M, Arregui N, Saeed N, Abdul-Aziz S, ALSayegh S, Humood M, Mohamed-Ali K, Swar S, Magray T, Aguiar-Portela T, Sugette-de-Aguiar T, Serpa-Maia F, Fernandes-Alves-de-Lima L, Teixeira-Josino L, Sampaio-Bezerra M, Furtado-Maia R, Romário-Mendes A, Alves-De-Oliveira A, Vasconcelos-Carneiro A, Anjos-Lima JD, Pinto-Coelho K, Maciel-Canuto M, Rocha-Batista M, Moreira T, Rodrigues-Amarilo N, Lima-de-Barros T, Guimarães KA, Batista C, Santos C, de-Lima-Silva F, Santos-Mota E, Karla L, Ferreira-de-Souza M, Luzia N, de-Oliveira S, Takeda C, Azevedo-Ferreira-Lima D, Faheina J, Coelho-Oliveira L, do-Nascimento S, Machado-Silva V, Bento-Ferreira, Olszewski J, Tenorio M, Silva-Lemos A, Ramos-Feijó C, Cardoso D, Correa-Barbosa M, Assunção-Ponte G, Faheina J, da-Silva-Escudero D, Servolo-Medeiros E, Andrade-Oliveira-Reis M, Kostadinov E, Dicheva V, Petrov M, Guo C, Yu H, Liu T, Song G, Wang C, Cañas-Giraldo L, Marin-Tobar D, Trujillo-Ramirez E, Andrea-Rios P, Álvarez-Moreno C, Linares C, González-Rubio P, Ariza-Ayala B, Gamba-Moreno L, Gualtero-Trujill S, Segura-Sarmiento S, Rodriguez-Pena J, Ortega R, Olarte N, Pardo-Lopez Y, Luis Marino Otela-Baicue A, Vargas-Garcia A, Roncancio E, Gomez-Nieto K, Espinosa-Valencia M, Barahona-Guzman N, Avila-Acosta C, Raigoza-Martinez W, Villamil-Gomez W, Chapeta-Parada E, Mindiola-Rochel A, Corchuelo-Martinez A, Martinez A, Lagares-Guzman A, Rodriguez-Ferrer M, Yepes-Gomez D, Muñoz-Gutierrez G, Arguello-Ruiz A, Zuniga-Chavarria M, Maroto-Vargas L, Valverde-Hernández M, Solano-Chinchilla A, Calvo-Hernandez I, Chavarria-Ugalde O, Tolari G, Rojas-Fermin R, Diaz-Rodriguez C, Huascar S, Ortiz M, Bovera M, Alquinga N, Santacruz G, Jara E, Delgado V, Salgado-Yepez E, Valencia F, Pelaez C, Gonzalez-Flores H, Coello-Gordon E, Picoita F, Arboleda M, Garcia M, Velez J, Valle M, Unigarro L, Figueroa V, Marin K, Caballero-Narvaez H, Bayani V, Ahmed S, Alansary A, Hassan A, Abdel-Halim M, El-Fattah M, Abdelaziz-Yousef R, Hala A, Abdelhady K, Ahmed-Fouad H, Mounir-Agha H, Hamza H, Salah Z, Abdel-Aziz D, Ibrahim S, Helal A, AbdelMassih A, Mahmoud AR, Elawady B, El-sherif R, Fattah-Radwan Y, Abdel-Mawla T, Kamal-Elden N, Kartsonaki M, Rivera D, Mandal S, Mukherjee S, Navaneet P, Padmini B, Sorabjee J, Sakle A, Potdar M, Mane D, Sale H, Abdul-Gaffar M, Kazi M, Chabukswar S, Anju M, Gaikwad D, Harshe A, Blessymole S, Nair P, Khanna D, Chacko F, Rajalakshmi A, Mubarak A, Kharbanda M, Kumar S, Mathur P, Saranya S, Abubakar F, Sampat S, Raut V, Biswas S, Kelkar R, Divatia J, Chakravarthy M, Gokul B, Sukanya R, Pushparaj L, Thejasvini A, Rangaswamy S, Saini N, Bhattacharya C, Das S, Sanyal S, Chaudhury B, Rodrigues C, Khanna G, Dwivedy A, Binu S, Shetty S, Eappen J, Valsa T, Sriram A, Todi S, Bhattacharyya M, Bhakta A, Ramachandran B, Krupanandan R, Sahoo P, Mohanty N, Sahu S, Misra S, Ray B, Pattnaik S, Pillai H, Warrier A, Ranganathan L, Mani A, Rajagopal S, Abraham B, Venkatraman R, Ramakrishnan N, Devaprasad D, Siva K, Divekar D, Satish Kavathekar M, Suryawanshi M, Poojary A, Sheeba J, Patil P, Kukreja S, Varma K, Narayanan S, Sohanlal T, Agarwal A, Agarwal M, Nadimpalli G, Bhamare S, Thorat S, Sarda O, Nadimpalli P, Nirkhiwale S, Gehlot G, Bhattacharya S, Pandya N, Raphel A, Zala D, Mishra S, Patel M, Aggarwal D, Jawadwal B, Pawar N, Kardekar S, Manked A, Tamboli A, Manked A, Khety Z, Singhal T, Shah S, Kothari V, Naik R, Narain R, Sengupta S, Karmakar A, Mishra S, Pati B, Kantroo V, Kansal S, Modi N, Chawla R, Chawla A, Roy I, Mukherjee S, Bej M, Mukherjee P, Baidya S, Durell A, Vadi S, Saseedharan S, Anant P, Edwin J, Sen N, Sandhu K, Pandya N, Sharma S, Sengupta S, Palaniswamy V, Sharma P, Selvaraj M, Saurabh L, Agarwal M, Punia D, Soni D, Misra R, Harsvardhan R, Azim A, Kambam C, Garg A, Ekta S, Lakhe M, Sharma C, Singh G, Kaur A, Singhal S, Chhabra K, Ramakrishnan G, Kamboj H, Pillai S, Rani P, Singla D, Sanaei A, Maghsudi B, Sabetian G, Masjedi M, Shafiee E, Nikandish R, Paydar S, Khalili H, Moradi A, Sadeghi P, Bolandparvaz S, Mubarak S, Makhlouf M, Awwad M, Ayyad O, Shaweesh A, Khader M, Alghazawi A, Hussien N, Alruzzieh M, Mohamed Y, ALazhary M, Abdul Aziz O, Alazmi M, Mendoza J, De Vera P, Rillorta A, de Guzman M, Girvan M, Torres M, Alzahrani N, Alfaraj S, Gopal U, Manuel M, Alshehri R, Lessing L, Alzoman H, Abdrahiem J, Adballah H, Thankachan J, Gomaa H, Asad T, AL-Alawi M, Al-Abdullah N, Demaisip N, Laungayan-Cortez E, Cabato A, Gonzales J, Al Raey M, Al-Darani S, Aziz M, Al-Manea B, Samy E, AlDalaton M, Alaliany M, Alabdely H, Helali N, Sindayen G, Malificio A, Al-Dossari H, Kelany A, Algethami A, Mohamed D, Yanne L, Tan A, Babu S, Abduljabbar S, Al-Zaydani M, Ahmed H, Al Jarie A, Al-Qathani A, Al-Alkami H, AlDalaton M, Alih S, Alaliany M, Gasmin-Aromin R, Balon-Ubalde E, Diab H, Kader N, Hassan-Assiry I, Kelany A, Albeladi E, Aboushoushah S, Qushmaq N, Fernandez J, Hussain W, Rajavel R, Bukhari S, Rushdi H, Turkistani A, Mushtaq J, Bohlega E, Simon S, Damlig E, Elsherbini S, Abraham S, Kaid E, Al-Attas A, Hawsawi G, Hussein B, Esam B, Caminade Y, Santos A, Abdulwahab M, Aldossary A, Al-Suliman S, AlTalib A, Albaghly N, HaqlreMia M, Kaid E, Altowerqi R, Ghalilah K, Alradady M, Al-Qatri A, Chaouali M, Shyrine E, Philipose J, Raees M, AbdulKhalik N, Madco M, Acostan C, Safwat R, Halwani M, Abdul-Aal N, Thomas A, Abdulatif S, Ali-Karrar M, Al-Gosn N, Al-Hindi A, Jaha R, AlQahtani S, Ayugat E, Al-Hussain M, Aldossary A, Al-Suliman S, Al-Talib A, Albaghly N, Haqlre-Mia M, Briones S, Krishnan R, Tabassum K, Alharbi L, Madani A, Al-Hindi A, Al-Gethamy M, Alamri D, Spahija G, Gashi A, Kurian A, George S, Mohamed A, Ramapurath R, Varghese S, Abdo N, Foda-Salama M, Al-Mousa H, Omar A, Salama M, Toleb M, Khamis S, Kanj S, Zahreddine N, Kanafani Z, Kardas T, Ahmadieh R, Hammoud Z, Zeid I, Al-Souheil A, Ayash H, Mahfouz T, Kondratas T, Grinkeviciute D, Kevalas R, Dagys A, Mitrev Z, Bogoevska-Miteva Z, Jankovska K, Guroska S, Petrovska M, Popovska K, Ng C, Hoon Y, Hasan YM, Othman-Jailani M, Hadi-Jamaluddin M, Othman A, Zainol H, Wan-Yusoff W, Gan C, Lum L, Ling C, Aziz F, Zhazali R, Abud-Wahab M, Cheng T, Elghuwael I, Wan-Mat W, Abd-Rahman R, Perez-Gomez H, Kasten-Monges M, Esparza-Ahumada S, Rodriguez-Noriega E, Gonzalez-Diaz E, Mayoral-Pardo D, Cerero-Gudino A, Altuzar-Figueroa M, Perez-Cruz J, Escobar-Vazquez M, Aragon D, Coronado-Magana H, Mijangos-Mendez J, Corona-Jimenez F, Aguirre-Avalos G, Lopez-Mateos A, Martinez-Marroquin M, Montell-Garcia M, Martinez-Martinez A, Leon-Sanchez E, Gomez-Flores G, Ramirez M, Gomez M, Lozano M, Mercado V, Zamudio-Lugo I, Gomez-Gonzalez C, Miranda-Novales M, Villegas-Mota I, Reyes-Garcia C, Ramirez-Morales M, Sanchez-Rivas M, Cureno-Diaz M, Matias-Tellez B, Gonzalez-Martinez J, Juarez-Vargas R, Pastor-Salinas O, Gutierrez-Munoz V, Conde-Mercado J, Bruno-Carrasco G, Manrique M, Monroy-Colin V, Cruz-Rivera Z, Rodriguez-Pacheco J, Cruz N, Hernandez-Chena B, Guido-Ramirez O, Arteaga-Troncoso G, Guerra-Infante F, Lopez-Hurtado M, Caleco JD, Leyva-Medellin E, Salamanca-Meneses A, Cosio-Moran C, Ruiz-Rendon R, Aguilar-Angel L, Sanchez-Vargas M, Mares-Morales R, Fernandez-Alvarez L, Castillo-Cruz B, Gonzalez-Ma M, Zavala-Ramír M, Rivera-Reyna L, del-Moral-Rossete L, Lopez-Rubio C, Valadez-de-Alba M, Bat-Erdene A, Chuluunchimeg K, Baatar O, Batkhuu B, Ariyasuren Z, Bayasgalan G, Baigalmaa S, Uyanga T, Suvderdene P, Enkhtsetseg D, Suvd-Erdene D, Chimedtseye E, Bilguun G, Tuvshinbayar M, Dorj M, Khajidmaa T, Batjargal G, Naranpurev M, Bat-Erdene A, Bolormaa T, Battsetseg T, Batsuren C, Batsaikhan N, Tsolmon B, Saranbaatar A, Natsagnyam P, Nyamdawa O, Madani N, Abouqal R, Zeggwagh A, Berechid K, Dendane T, Koirala A, Giri R, Sainju S, Acharya S, Paul N, Parveen A, Raza A, Nizamuddin S, Sultan F, Imran X, Sajjad R, Khan M, Sana F, Tayyab N, Ahmed A, Zaman G, Khan I, Khurram F, Hussain A, Zahra F, Imtiaz A, Daud N, Sarwar M, Roop Z, Yusuf S, Hanif F, Shumaila X, Zeb J, Ali S, Demas S, Ariff S, Riaz A, Hussain A, Kanaan A, Jeetawi R, Castaño E, Moreno-Castillo L, García-Mayorca E, Prudencio-Leon W, Vivas-Pardo A, Changano-Rodriguez M, Castillo-Bravo L, Aibar-Yaranga K, Marquez-Mondalgo V, Mueras-Quevedo J, Meza-Borja C, Flor J, Fernandez-Camacho Y, Banda-Flores C, Pichilingue-Chagray J, Castaneda-Sabogal A, Caoili J, Mariano M, Maglente R, Santos S, de-Guzman G, Mendoza M, Javellana O, Tajanlangit A, Tapang A, Sg-Buenaflor M, Labro E, Carma R, Dy A, Fortin J, Navoa-Ng J, Cesar J, Bonifacio B, Llames M, Gata H, Tamayo A, Calupit H, Catcho V, Bergosa L, Abuy M, Barteczko-Grajek B, Rojek S, Szczesny A, Domanska M, Lipinska G, Jaroslaw J, Wieczoreka A, Szczykutowicza A, Gawor M, Piwoda M, Rydz-Lutrzykowska J, Grudzinska M, Kolat-Brodecka P, Smiechowicz K, Tamowicz B, Mikstacki A, Grams A, Sobczynski P, Nowicka M, Kretov V, Shalapuda V, Molkov A, Puzanov S, Utkin I, Tchekulaev A, Tulupova V, Vasiljevic S, Nikolic L, Ristic G, Eremija J, Kojovic J, Lekic D, Simic A, Hlinkova S, Lesnakova A, Kadankunnel S, Abdo-Ali M, Pimathai R, Wanitanukool S, Supa N, Prasan P, Luxsuwong M, Khuenkaew Y, Lamngamsupha J, Siriyakorn N, Prasanthai V, Apisarnthanarak A, Borgi A, Bouziri A, Cabadak H, Tuncer G, Bulut C, Hatipoglu C, Sebnem F, Demiroz A, Kaya A, Ersoz G, Kuyucu N, Karacorlu S, Oncul O, Gorenek L, Erdem H, Yildizdas D, Horoz O, Guclu E, Kaya G, Karabay O, Altindis M, Oztoprak N, Sahip Y, Uzun C, Erben N, Usluer G, Ozgunes I, Ozcelik M, Ceyda B, Oral M, Unal N, Cigdem Y, Bayar M, Bermede O, Saygili S, Yesiler I, Memikoglu O, Tekin R, Oncul A, Gunduz A, Ozdemir D, Geyik M, Erdogan S, Aygun C, Dilek A, Esen S, Turgut H, Sungurtekin H, Ugurcan D, Yarar V, Bilir Y, Bayram N, Devrim I, Agin H, Ceylan G, Yasar N, Oruc Y, Ramazanoglu A, Turhan O, Cengiz M, Yalcin A, Dursun O, Gunasan P, Kaya S, Senol G, Kocagoz A, Al-Rahma H, Annamma P, El-Houfi A, Vidal H, Perez F, D-Empaire G, Ruiz Y, Hernandez D, Aponte D, Salinas E, Vidal H, Navarrete N, Vargas R, Sanchez E, Ngo Quy C, Thu T, Nguyet L, Hang P, Hang T, Hanh T, Anh D. International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2012-2017: Device-associated module. Am J Infect Control 2020; 48:423-432. [PMID: 31676155 DOI: 10.1016/j.ajic.2019.08.023] [Citation(s) in RCA: 61] [Impact Index Per Article: 15.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2019] [Revised: 08/20/2019] [Accepted: 08/21/2019] [Indexed: 12/18/2022]
Abstract
BACKGROUND We report the results of International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2012 to December 2017 in 523 intensive care units (ICUs) in 45 countries from Latin America, Europe, Eastern Mediterranean, Southeast Asia, and Western Pacific. METHODS During the 6-year study period, prospective data from 532,483 ICU patients hospitalized in 242 hospitals, for an aggregate of 2,197,304 patient days, were collected through the INICC Surveillance Online System (ISOS). The Centers for Disease Control and Prevention-National Healthcare Safety Network (CDC-NHSN) definitions for device-associated health care-associated infection (DA-HAI) were applied. RESULTS Although device use in INICC ICUs was similar to that reported from CDC-NHSN ICUs, DA-HAI rates were higher in the INICC ICUs: in the medical-surgical ICUs, the pooled central line-associated bloodstream infection rate was higher (5.05 vs 0.8 per 1,000 central line-days); the ventilator-associated pneumonia rate was also higher (14.1 vs 0.9 per 1,000 ventilator-days,), as well as the rate of catheter-associated urinary tract infection (5.1 vs 1.7 per 1,000 catheter-days). From blood cultures samples, frequencies of resistance, such as of Pseudomonas aeruginosa to piperacillin-tazobactam (33.0% vs 18.3%), were also higher. CONCLUSIONS Despite a significant trend toward the reduction in INICC ICUs, DA-HAI rates are still much higher compared with CDC-NHSN's ICUs representing the developed world. It is INICC's main goal to provide basic and cost-effective resources, through the INICC Surveillance Online System to tackle the burden of DA-HAIs effectively.
Collapse
|
20
|
González-Fortes G, Tassi F, Trucchi E, Henneberger K, Paijmans JLA, Díez-Del-Molino D, Schroeder H, Susca RR, Barroso-Ruíz C, Bermudez FJ, Barroso-Medina C, Bettencourt AMS, Sampaio HA, Grandal-d'Anglade A, Salas A, de Lombera-Hermida A, Fabregas Valcarce R, Vaquero M, Alonso S, Lozano M, Rodríguez-Alvarez XP, Fernández-Rodríguez C, Manica A, Hofreiter M, Barbujani G. A western route of prehistoric human migration from Africa into the Iberian Peninsula. Proc Biol Sci 2020; 286:20182288. [PMID: 30963949 DOI: 10.1098/rspb.2018.2288] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
Abstract
Being at the western fringe of Europe, Iberia had a peculiar prehistory and a complex pattern of Neolithization. A few studies, all based on modern populations, reported the presence of DNA of likely African origin in this region, generally concluding it was the result of recent gene flow, probably during the Islamic period. Here, we provide evidence of much older gene flow from Africa to Iberia by sequencing whole genomes from four human remains from northern Portugal and southern Spain dated around 4000 years BP (from the Middle Neolithic to the Bronze Age). We found one of them to carry an unequivocal sub-Saharan mitogenome of most probably West or West-Central African origin, to our knowledge never reported before in prehistoric remains outside Africa. Our analyses of ancient nuclear genomes show small but significant levels of sub-Saharan African affinity in several ancient Iberian samples, which indicates that what we detected was not an occasional individual phenomenon, but an admixture event recognizable at the population level. We interpret this result as evidence of an early migration process from Africa into the Iberian Peninsula through a western route, possibly across the Strait of Gibraltar.
Collapse
Affiliation(s)
- G González-Fortes
- 1 Department of Life Science and Biotechnology, University of Ferrara , 44121 Ferrara , Italy
| | - F Tassi
- 1 Department of Life Science and Biotechnology, University of Ferrara , 44121 Ferrara , Italy
| | - E Trucchi
- 1 Department of Life Science and Biotechnology, University of Ferrara , 44121 Ferrara , Italy
| | - K Henneberger
- 2 Institute for Biochemistry and Biology, University of Potsdam , 14476 Potsdam OT Golm , Germany
| | - J L A Paijmans
- 2 Institute for Biochemistry and Biology, University of Potsdam , 14476 Potsdam OT Golm , Germany
| | - D Díez-Del-Molino
- 3 Department of Bioinformatics and Genetics, Swedish Museum of Natural History , 104 05 Stockholm , Sweden
| | - H Schroeder
- 4 Section for Evolutionary Genomics, Natural History Museum of Denmark, University of Copenhagen , 1353 Copenhagen K , Denmark
| | - R R Susca
- 1 Department of Life Science and Biotechnology, University of Ferrara , 44121 Ferrara , Italy
| | - C Barroso-Ruíz
- 5 Fundación Instituto de Investigación de Prehistoria y Evolución Humana (FIPEH) , 14900 Lucena, Córdoba , Spain
| | - F J Bermudez
- 5 Fundación Instituto de Investigación de Prehistoria y Evolución Humana (FIPEH) , 14900 Lucena, Córdoba , Spain
| | - C Barroso-Medina
- 5 Fundación Instituto de Investigación de Prehistoria y Evolución Humana (FIPEH) , 14900 Lucena, Córdoba , Spain
| | - A M S Bettencourt
- 6 Landscape, Heritage and Territory Laboratory-Lab2PT, Department of History, University of Minho , 4700-057 Braga , Portugal
| | - H A Sampaio
- 7 Landscape, Heritage and Territory Laboratory-Lab2PT, Department of Hospitality and Tourism, Polytechnic Institute of Cávado and Ave , Barcelos , Portugal
| | - A Grandal-d'Anglade
- 8 Universitary Institute of Geology, University of Coruña , A Coruña 15081 , Spain
| | - A Salas
- 9 Unidade de Xenética, Instituto de Ciencias Forenses, Universidade de Santiago de Compostela, and GenPoB (IDIS-SERGAS) , Galicia , Spain
| | - A de Lombera-Hermida
- 10 Department of History GEPN-AAT, University of Santiago de Compostela , 15782 Santiago de Compostela , Spain
| | - R Fabregas Valcarce
- 10 Department of History GEPN-AAT, University of Santiago de Compostela , 15782 Santiago de Compostela , Spain
| | - M Vaquero
- 11 Department of History and History of Art, Rovira i Virgili University , 43002 Tarragona , Spain.,12 Institut Català de Paleoecologia Humana i Evolució Social (IPHES) , 43007 Tarragona , Spain
| | - S Alonso
- 11 Department of History and History of Art, Rovira i Virgili University , 43002 Tarragona , Spain.,12 Institut Català de Paleoecologia Humana i Evolució Social (IPHES) , 43007 Tarragona , Spain
| | - M Lozano
- 11 Department of History and History of Art, Rovira i Virgili University , 43002 Tarragona , Spain.,12 Institut Català de Paleoecologia Humana i Evolució Social (IPHES) , 43007 Tarragona , Spain
| | - X P Rodríguez-Alvarez
- 11 Department of History and History of Art, Rovira i Virgili University , 43002 Tarragona , Spain.,12 Institut Català de Paleoecologia Humana i Evolució Social (IPHES) , 43007 Tarragona , Spain
| | | | - A Manica
- 14 Department of Zoology, University of Cambridge , Cambridge CB2 3EJ , UK
| | - M Hofreiter
- 2 Institute for Biochemistry and Biology, University of Potsdam , 14476 Potsdam OT Golm , Germany
| | - G Barbujani
- 1 Department of Life Science and Biotechnology, University of Ferrara , 44121 Ferrara , Italy
| |
Collapse
|
21
|
Butler PA, Gaffney LP, Spagnoletti P, Abrahams K, Bowry M, Cederkäll J, de Angelis G, De Witte H, Garrett PE, Goldkuhle A, Henrich C, Illana A, Johnston K, Joss DT, Keatings JM, Kelly NA, Komorowska M, Konki J, Kröll T, Lozano M, Nara Singh BS, O'Donnell D, Ojala J, Page RD, Pedersen LG, Raison C, Reiter P, Rodriguez JA, Rosiak D, Rothe S, Scheck M, Seidlitz M, Shneidman TM, Siebeck B, Sinclair J, Smith JF, Stryjczyk M, Van Duppen P, Vinals S, Virtanen V, Warr N, Wrzosek-Lipska K, Zielińska M. Evolution of Octupole Deformation in Radium Nuclei from Coulomb Excitation of Radioactive ^{222}Ra and ^{228}Ra Beams. Phys Rev Lett 2020; 124:042503. [PMID: 32058764 DOI: 10.1103/physrevlett.124.042503] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/15/2019] [Indexed: 06/10/2023]
Abstract
There is sparse direct experimental evidence that atomic nuclei can exhibit stable "pear" shapes arising from strong octupole correlations. In order to investigate the nature of octupole collectivity in radium isotopes, electric octupole (E3) matrix elements have been determined for transitions in ^{222,228}Ra nuclei using the method of sub-barrier, multistep Coulomb excitation. Beams of the radioactive radium isotopes were provided by the HIE-ISOLDE facility at CERN. The observed pattern of E3 matrix elements for different nuclear transitions is explained by describing ^{222}Ra as pear shaped with stable octupole deformation, while ^{228}Ra behaves like an octupole vibrator.
Collapse
Affiliation(s)
- P A Butler
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - L P Gaffney
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
- ISOLDE, CERN, 1211 Geneva 23, Switzerland
| | - P Spagnoletti
- University of the West of Scotland, Paisley PA1 2BE, United Kingdom
| | - K Abrahams
- University of the Western Cape, Private Bag X17, Bellville 7535, South Africa
| | - M Bowry
- University of the West of Scotland, Paisley PA1 2BE, United Kingdom
- TRIUMF, Vancouver V6T 2A3 BC, Canada
| | - J Cederkäll
- Lund University, Box 118, Lund SE-221 00, Sweden
| | - G de Angelis
- INFN Laboratori Nazionali di Legnaro, Legnaro 35020 PD, Italy
| | | | - P E Garrett
- University of Guelph, Guelph N1G 2W1 Ontario, Canada
| | - A Goldkuhle
- University of Cologne, Cologne 50937, Germany
| | - C Henrich
- Technische Universität Darmstadt, Darmstadt 64289, Germany
| | - A Illana
- INFN Laboratori Nazionali di Legnaro, Legnaro 35020 PD, Italy
| | - K Johnston
- ISOLDE, CERN, 1211 Geneva 23, Switzerland
| | - D T Joss
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - J M Keatings
- University of the West of Scotland, Paisley PA1 2BE, United Kingdom
| | - N A Kelly
- University of the West of Scotland, Paisley PA1 2BE, United Kingdom
| | - M Komorowska
- Heavy Ion Laboratory, University of Warsaw, Warsaw PL-02-093, Poland
| | - J Konki
- ISOLDE, CERN, 1211 Geneva 23, Switzerland
| | - T Kröll
- Technische Universität Darmstadt, Darmstadt 64289, Germany
| | - M Lozano
- ISOLDE, CERN, 1211 Geneva 23, Switzerland
| | - B S Nara Singh
- University of the West of Scotland, Paisley PA1 2BE, United Kingdom
| | - D O'Donnell
- University of the West of Scotland, Paisley PA1 2BE, United Kingdom
| | - J Ojala
- University of Jyvaskyla, P.O. Box 35, Jyvaskyla FIN-40014, Finland
- Helsinki Institute of Physics, P.O. Box 64, Helsinki FIN-00014, Finland
| | - R D Page
- University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - L G Pedersen
- University of Oslo, P.O. Box 1048, Oslo N-0316, Norway
| | - C Raison
- University of York, York YO10 5DD, United Kingdom
| | - P Reiter
- University of Cologne, Cologne 50937, Germany
| | | | - D Rosiak
- University of Cologne, Cologne 50937, Germany
| | - S Rothe
- ISOLDE, CERN, 1211 Geneva 23, Switzerland
| | - M Scheck
- University of the West of Scotland, Paisley PA1 2BE, United Kingdom
| | - M Seidlitz
- University of Cologne, Cologne 50937, Germany
| | - T M Shneidman
- Joint Institute for Nuclear Research, RU-141980 Dubna, Russian Federation
| | - B Siebeck
- University of Cologne, Cologne 50937, Germany
| | - J Sinclair
- University of the West of Scotland, Paisley PA1 2BE, United Kingdom
| | - J F Smith
- University of the West of Scotland, Paisley PA1 2BE, United Kingdom
| | | | | | - S Vinals
- Consejo Superior De Investigaciones Científicas, Madrid S28040, Spain
| | - V Virtanen
- University of Jyvaskyla, P.O. Box 35, Jyvaskyla FIN-40014, Finland
- Helsinki Institute of Physics, P.O. Box 64, Helsinki FIN-00014, Finland
| | - N Warr
- University of Cologne, Cologne 50937, Germany
| | - K Wrzosek-Lipska
- Heavy Ion Laboratory, University of Warsaw, Warsaw PL-02-093, Poland
| | - M Zielińska
- IRFU CEA, Université Paris-Saclay, Gif-sur-Yvette F-91191, France
| |
Collapse
|
22
|
Butler PA, Gaffney LP, Spagnoletti P, Konki J, Scheck M, Smith JF, Abrahams K, Bowry M, Cederkäll J, Chupp T, de Angelis G, De Witte H, Garrett PE, Goldkuhle A, Henrich C, Illana A, Johnston K, Joss DT, Keatings JM, Kelly NA, Komorowska M, Kröll T, Lozano M, Nara Singh BS, O'Donnell D, Ojala J, Page RD, Pedersen LG, Raison C, Reiter P, Rodriguez JA, Rosiak D, Rothe S, Shneidman TM, Siebeck B, Seidlitz M, Sinclair J, Stryjczyk M, Van Duppen P, Vinals S, Virtanen V, Warr N, Wrzosek-Lipska K, Zielinska M. The observation of vibrating pear-shapes in radon nuclei. Nat Commun 2019; 10:2473. [PMID: 31171788 PMCID: PMC6554308 DOI: 10.1038/s41467-019-10494-5] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2019] [Accepted: 05/15/2019] [Indexed: 11/09/2022] Open
Abstract
There is a large body of evidence that atomic nuclei can undergo octupole distortion and assume the shape of a pear. This phenomenon is important for measurements of electric-dipole moments of atoms, which would indicate CP violation and hence probe physics beyond the Standard Model of particle physics. Isotopes of both radon and radium have been identified as candidates for such measurements. Here, we observed the low-lying quantum states in 224Rn and 226Rn by accelerating beams of these radioactive nuclei. We show that radon isotopes undergo octupole vibrations but do not possess static pear-shapes in their ground states. We conclude that radon atoms provide less favourable conditions for the enhancement of a measurable atomic electric-dipole moment.
Collapse
Affiliation(s)
- P A Butler
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK.
| | - L P Gaffney
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK.,CERN, Geneva 23, CH-1211, Switzerland
| | - P Spagnoletti
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - J Konki
- CERN, Geneva 23, CH-1211, Switzerland
| | - M Scheck
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - J F Smith
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - K Abrahams
- Department of Physics & Astronomy, University of the Western Cape, Private Bag X17, Bellville, 7535, South Africa
| | - M Bowry
- TRIUMF, Vancouver, V6T 2A3, BC, Canada
| | - J Cederkäll
- Physics Department, Lund University, Box 118, Lund, SE-221 00, Sweden
| | - T Chupp
- Department of Physics, University of Michigan, Ann Arbor, 48104, MI, USA
| | - G de Angelis
- INFN Laboratori Nazionali di Legnaro, Legnaro, 35020, PD, Italy
| | - H De Witte
- Instituut voor Kern- en Stralingsfysica, KU Leuven, Leuven, B-3001, Belgium
| | - P E Garrett
- Department of Physics, University of Guelph, Guelph, N1G 2W1, Ontario, Canada
| | - A Goldkuhle
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - C Henrich
- Institut für Kernphysik, Technische Universität Darmstadt, Darmstadt, 64289, Germany
| | - A Illana
- INFN Laboratori Nazionali di Legnaro, Legnaro, 35020, PD, Italy
| | | | - D T Joss
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK
| | - J M Keatings
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - N A Kelly
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - M Komorowska
- Heavy Ion Laboratory, University of Warsaw, Warsaw, PL-02-093, Poland
| | - T Kröll
- Institut für Kernphysik, Technische Universität Darmstadt, Darmstadt, 64289, Germany
| | - M Lozano
- CERN, Geneva 23, CH-1211, Switzerland
| | - B S Nara Singh
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - D O'Donnell
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - J Ojala
- Department of Physics, University of Jyvaskyla, P.O. Box 35, Jyvaskyla, FIN-40014, Finland.,Helsinki Institute of Physics, P.O. Box 64, Helsinki, FIN-00014, Finland
| | - R D Page
- Oliver Lodge Laboratory, University of Liverpool, Liverpool, L69 7ZE, UK
| | - L G Pedersen
- Department of Physics, University of Oslo, P.O. Box 1048, Oslo, N-0316, Norway
| | - C Raison
- Department of Physics, University of York, York, YO10 5DD, UK
| | - P Reiter
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | | | - D Rosiak
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - S Rothe
- CERN, Geneva 23, CH-1211, Switzerland
| | | | - B Siebeck
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - M Seidlitz
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - J Sinclair
- School of Computing, Engineering and Physical Sciences, University of the West of Scotland, Paisley, PA1 2BE, UK
| | - M Stryjczyk
- Instituut voor Kern- en Stralingsfysica, KU Leuven, Leuven, B-3001, Belgium
| | - P Van Duppen
- Instituut voor Kern- en Stralingsfysica, KU Leuven, Leuven, B-3001, Belgium
| | - S Vinals
- Consejo Superior De Investigaciones Científicas, Madrid, S 28040, Spain
| | - V Virtanen
- Department of Physics, University of Jyvaskyla, P.O. Box 35, Jyvaskyla, FIN-40014, Finland.,Helsinki Institute of Physics, P.O. Box 64, Helsinki, FIN-00014, Finland
| | - N Warr
- Institute for Nuclear Physics, University of Cologne, Cologne, 50937, Germany
| | - K Wrzosek-Lipska
- Heavy Ion Laboratory, University of Warsaw, Warsaw, PL-02-093, Poland
| | - M Zielinska
- IRFU CEA, Université Paris-Saclay, Gif-sur-Yvette, F-91191, France
| |
Collapse
|
23
|
Yazer MH, Spinella PC, Allard S, Roxby D, So-Osman C, Lozano M, Gunn K, Shih AW, Stensballe J, Johansson PI, Bagge Hansen M, Maegele M, Doughty H, Crombie N, Jenkins DH, McGinity AC, Schaefer RM, Martinaud C, Shinar E, Strugo R, Chen J, Russcher H. Vox Sanguinis International Forum on the use of prehospital blood products and pharmaceuticals in the treatment of patients with traumatic hemorrhage. Vox Sang 2018; 113:816-830. [DOI: 10.1111/vox.12677] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
| | | | | | - D. Roxby
- SA Pathology Transfusion Medicine; Flinders Medical Centre; Flinders Drive Bedford Park SA 5042 Australia
| | | | | | - K. Gunn
- Department of Anaesthesia; Auckland City Hospital; 2 Park Road Grafton, Auckland 1023 New Zealand
| | - A. W. Shih
- Vancouver General Hospital; Department of Pathology and Laboratory Medicine; 855 West 12th Avenue Vancouver BC V5Z 1M9 Canada
| | - J. Stensballe
- Rigshospitalet; Section for Transfusion Medicine; Copenhagen University Hospital; Capital Region Blood Bank; Blegdamsvej 9 Copenhagen 2100 Denmark
| | - P. I. Johansson
- Rigshospitalet; Section for Transfusion Medicine; Copenhagen University Hospital; Capital Region Blood Bank; Blegdamsvej 9 Copenhagen 2100 Denmark
| | - M. Bagge Hansen
- Klinikchef; Rigshospitalet; Klinisk Immulogisk Afd. 2034, Blegdamsvej 9 2100 København Ø Denmark
| | - M. Maegele
- Department of Traumatology and Orthopedic Surgery; Cologne-Merheim Medical Center (CMMC); Institute for Research in Operative Medicine (IFOM); University Witten/Herdecke (UW/H); Ostmerheimerstr. 200 D-51109 Köln Germany
| | - H. Doughty
- NHS Blood and Transplant; Vincent Drive Birmingham UK
- Department of Clinical Traumatology; University Hospitals Birmingham NHS Foundation Trust; Birmingham UK
| | - N. Crombie
- University Hospitals Birmingham NHS Foundation Trust; Birmingham UK
- National Institute for Health Research SRMRC
| | - D. H. Jenkins
- Department of Surgery; UT Health San Antonio; 7703 Floyd Curl Dr San Antonio TX 78229 USA
| | - A. C. McGinity
- Department of Surgery; UT Health San Antonio; 7703 Floyd Curl Dr San Antonio TX 78229 USA
| | - R. M. Schaefer
- Research; Southwest Texas Regional Advisory Council; 7500 US-90 West San Antonio TX 78227 USA
| | - C. Martinaud
- Chief of Clinical Operations; French Military Blood Institute; 1 rue du Lieutenant Raoul Batany, 92 141 Clamart Cedex France
| | - E. Shinar
- Magen David Adom; Ramat Gan 5262100 Israel
| | - R. Strugo
- Magen David Adom; Yigal Alon 60 Tel Aviv 67062 Israel
| | - J. Chen
- Trauma and Combat Medicine Branch; Surgeon General's Headquarters; Israel Defense Force; Ramat Gan Israel
| | - H. Russcher
- Specialist Laboratory Medicine; Dep. Clinical Chemistry; Blood Transfusion Laboratory Erasmus MC; University Medical Center, Rotterdam; Dr. Molewaterplein 60 3015 GD Rotterdam The Netherlands
| |
Collapse
|
24
|
Español Rego M, Alonso V, Aparicio J, Elez Fernandez E, Escudero P, Fernández-Martos C, Rodríguez N, Ruiz Casado A, Cid J, Cabezón R, Lozano M, Ginés A, Bianchi L, Garcia-Corbacho J, García de Albéniz X, Maurel J, Benitez Ribas D. AVEVAC: A phase I-II trial with avelumab plus autologous dendritic cell (ADC) vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer (mCRC) patients (GEMCAD 16-02). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy281.156] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
25
|
|
26
|
Yazer MH, Spinella PC, Allard S, Roxby D, So-Osman C, Lozano M, Gunn K, Shih AWY, Stensballe J, Johansson PI, Bagge Hansen M, Maegele M, Doughty H, Crombie N, Jenkins DH, McGinity A, Schaefer RM, Martinaud C, Shinar E, Strugo R, Chen J, Russcher H. Vox Sanguinis International Forum on the use of prehospital blood products and pharmaceuticals in the treatment of patients with traumatic haemorrhage. Vox Sang 2018; 113:701-706. [PMID: 30144091 DOI: 10.1111/vox.12678] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
While specific practices and transported blood products vary around the world, most of the respondents in this International Forum transported at least one blood product for the transfusion to bleeding patients en route to the hospital. The most commonly carried product was RBCs, while the use of whole blood will likely increase given the recent reports of its successful use in the civilian setting, and because of the change in the AABB's Standards regulating its use. It will be interesting to see if plasma use in the prehospital setting becomes more widely used given today's enhanced appreciated of the coagulopathy of trauma and plasma's beneficial effect in reversing it, and if blood products are transported to the scene of injury by more vehicles, that is, not just predominantly in helicopters. It was not surprising that TXA is being widely administered as close to the time of injury as possible given its potential benefit in these patients. This International Forum highlights the importance of focusing attention on prehospital transfusion management with a need to further high‐quality research in this area to guide optimal resuscitation strategies.
Collapse
Affiliation(s)
- M H Yazer
- Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA
| | - P C Spinella
- Pediatric Critical Care Translational Research Program, Department of Pediatrics, Washington University in St Louis School of Medicine, St Louis, MO, USA
| | - S Allard
- Clinical, NHS Blood and Transplant, NHSBT, London, UK
| | - D Roxby
- SA Pathology Transfusion Service, Flinders Medical Centre, Bedford Park, SA, Australia
| | - C So-Osman
- Department of Transfusion Medicine, Sanquin Bloodbank, Leiden, The Netherlands.,Department of Internal Medicine, Groene Hart Hospital, Gouda, The Netherlands
| | - M Lozano
- Department of Hemotherapy and Hemostasis, Hospital Clinic, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Bellucci S, Girma JP, Lozano M, Meyer D, Caen JP. Impaired Prothrombin Consumption in Bernard-Soulier Syndrome Is Corrected In Vitro by Human Factor VIII. Thromb Haemost 2018. [DOI: 10.1055/s-0038-1655972] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
SummaryThe Bernard-Soulier syndrome (BSS) is characterized by thrombocytopenia with giant platelets, a prolonged bleeding time with defective platelet adhesion to the subendothelium related to a defect in platelet membrane glycoprotein lb (GPIb) and a decreased prothrombin consumption. The mechanism of the latter abnormality remains unknown. In this study, we showed that this defect was corrected by the addition of purified human factor VIII (FVIII) to blood from four patients with BSS. The correction of prothrombin consumption was almost complete at concentrations between 1.5 and 3 IU/ml of FVIII procoagulant activity (VIII.'C) and partially abolished by a monoclonal antibody which neutralizes VIII:C. This correction was specific for FVIII and was not observed after addition of purified human FIX. It was obtained, in the same magnitude range, with FVIII complexed to von Willebrand factor (vWF) but not with free vWF. These data provide a new insight into the knowledge of the physiological interaction between the platelet membrane and the vWF-FVIII complex facilitating plasma coagulation activation and may lead to helpful therapeutic advances.
Collapse
Affiliation(s)
- S Bellucci
- Laboratory of Hematology and Institut des Vaisseaux et du Sang, Hôpital Lariboisière, Paris
| | - J P Girma
- Inserm U.143. Hôpital de Bicêtre, Le Kremlin-Bicêtre, France
| | - M Lozano
- Haemotherapy and Haemostasis Department, Hospital Clinic, Barcelona, Spain
| | - D Meyer
- Inserm U.143. Hôpital de Bicêtre, Le Kremlin-Bicêtre, France
| | - J P Caen
- Laboratory of Hematology and Institut des Vaisseaux et du Sang, Hôpital Lariboisière, Paris
| |
Collapse
|
28
|
De Vooght KMK, Lozano M, Bueno JL, Alarcón A, Romera I, Suzuki K, Zhiburt E, Holbro A, Infanti L, Buser A, Hustinx H, Deneys V, Frélik A, Thiry C, Murphy M, Staves J, Selleng K, Greinacher A, Kutner JM, Bonet Bub C, Castilho L, Kaufman RM, Colling ME, Perseghin P, Incontri A, Dassi M, Brilhante D, Macédo A, Cserti-Gazdewich C, Pendergrast JM, Hawes J, Lundgren MN, Storry JR, Jain A, Marwaha N, Sharma RR. International Forum on typing and matching strategies in patients on anti-CD38 monoclonal therapy. Vox Sang 2018; 113. [PMID: 29947125 DOI: 10.1111/vox.12652] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
| | | | - J-L Bueno
- Haematology and Haemotherapy Department, Hospital Universitario Puerta de Hierro - Majadahonda, Joaquín Rodrigo 2, Majadahonda, 28222, Madrid, Spain
| | - A Alarcón
- Haematology and Haemotherapy Department, Hospital Universitario Puerta de Hierro - Majadahonda, Joaquín Rodrigo 2, Majadahonda, 28222, Madrid, Spain
| | - I Romera
- Haematology and Haemotherapy Department, Hospital Universitario Puerta de Hierro - Majadahonda, Joaquín Rodrigo 2, Majadahonda, 28222, Madrid, Spain
| | - K Suzuki
- Department of Internal Medicine, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8935, Japan
| | - E Zhiburt
- Blood Transfusion Department, Pirogov Russian National Medical Surgical Center, 70, Nizhnyaya Pervomaiskaya ul, Moscow, 105203, Russia
| | - A Holbro
- Regional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland
- Hematology, University Hospital Basel, Hebelstrasse 10, Basel, 4031, Switzerland
| | - L Infanti
- Regional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland
- Hematology, University Hospital Basel, Hebelstrasse 10, Basel, 4031, Switzerland
| | - A Buser
- Regional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland
- Hematology, University Hospital Basel, Hebelstrasse 10, Basel, 4031, Switzerland
| | - H Hustinx
- National Reference Laboratory, Swiss Blood Transfusion Service, Interregional Blood Transfusion Service SRC Ltd, Murtenstrasse 133, Bern, 3008, Switzerland
| | - V Deneys
- Immunohematology Laboratory, CHU UCL Namur, Godinne Hospital, Rue Dr Gaston Therasse 1, 5530, Yvoir, Belgium
| | - A Frélik
- Immunohematology Laboratory, CHU UCL Namur, Godinne Hospital, Rue Dr Gaston Therasse 1, 5530, Yvoir, Belgium
| | - C Thiry
- Immunohematology Laboratory, CHU UCL Namur, Godinne Hospital, Rue Dr Gaston Therasse 1, 5530, Yvoir, Belgium
| | - M Murphy
- NHS Blood & Transplant, Oxford University Hospitals, NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9DU, UK
| | - J Staves
- Oxford University Hospitals, NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9DU, UK
| | - K Selleng
- Institut für Immunologie und Transfusionsmedizin, Universitätsmedizin Greifswald, Sauerbruchstr, Greifswald, 17475, Germany
| | - A Greinacher
- Institut für Immunologie und Transfusionsmedizin, Universitätsmedizin Greifswald, Sauerbruchstr, Greifswald, 17475, Germany
| | - J M Kutner
- Departamento de Hemoterapia, Hospital Israelita Albert Einstein, Av. Albert Einstein, 627/701 - Morumbi, São Paulo - SP, 05652-900, Brazil
| | - C Bonet Bub
- Departamento de Hemoterapia, Hospital Israelita Albert Einstein, Av. Albert Einstein, 627/701 - Morumbi, São Paulo - SP, 05652-900, Brazil
| | - L Castilho
- Departamento de Hemoterapia, Hospital Israelita Albert Einstein, Av. Albert Einstein, 627/701 - Morumbi, São Paulo - SP, 05652-900, Brazil
| | - R M Kaufman
- Brigham and Women's Hospital, Blood Bank, Amory 260, 75 Francis Street, Boston, MA, 02115, USA
| | - M E Colling
- Brigham and Women's Hospital, Blood Bank, Amory 260, 75 Francis Street, Boston, MA, 02115, USA
| | - P Perseghin
- Laboratorio di Criobiologia, UOS Aferesi e nuove tecnologie trasfusionali, ASST-Monza Ospedale San Gerardo, Via Pergolesi 33, 20900, Monza, Italy
| | - A Incontri
- Laboratorio di Immunoematologia, UOS Aferesi e nuove tecnologie trasfusionale, ASST-Monza, Ospedale San Gerardo, Via Pergolesi 33, 20900, Monza, Italy
| | - M Dassi
- Laboratorio di Immunoematologia, UOS Aferesi e nuove tecnologie trasfusionale, ASST-Monza, Ospedale San Gerardo, Via Pergolesi 33, 20900, Monza, Italy
| | - D Brilhante
- Serviço de Imunohemoterapia, Instituto Português de Oncologia Lisboa Francisco Gentil, EPE, Lisboa, Portugal
| | - A Macédo
- Serviço de Imunohemoterapia, Instituto Português de Oncologia Lisboa Francisco Gentil, EPE, Lisboa, Portugal
| | - C Cserti-Gazdewich
- Department of Laboratory Hematology (Transfusion Medicine), University Health Network, 200 Elizabeth Street, UHN TGH BTL 3EC-306, Toronto, ON, M5G 2C4, Canada
| | - J M Pendergrast
- Department of Laboratory Hematology (Transfusion Medicine), University Health Network, 200 Elizabeth Street, UHN TGH BTL 3EC-306, Toronto, ON, M5G 2C4, Canada
| | - J Hawes
- Department of Laboratory Hematology (Transfusion Medicine), University Health Network, 200 Elizabeth Street, UHN TGH BTL 3EC-306, Toronto, ON, M5G 2C4, Canada
| | - M N Lundgren
- Deparment of Clinical Immunology and Transfusion Medicine, Labmedicin Skane, Akutgatan 8, Lund, SE-22185, Sweden
| | - J R Storry
- Deparment of Clinical Immunology and Transfusion Medicine, Labmedicin Skane, Akutgatan 8, Lund, SE-22185, Sweden
| | - A Jain
- Department of Transfusion Medicine, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012, India
| | - N Marwaha
- Department of Transfusion Medicine, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012, India
| | - R R Sharma
- Department of Transfusion Medicine, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012, India
| |
Collapse
|
29
|
de Vooght KMK, Lozano M, Bueno JL, Alarcón A, Romera I, Suzuki K, Zhiburt E, Holbro A, Infanti L, Buser A, Hustinx H, Deneys V, Frélik A, Thiry C, Murphy M, Staves J, Selleng K, Greinacher A, Kutner JM, Bonet Bub C, Castilho L, Kaufman R, Colling ME, Perseghin P, Incontri A, Dassi M, Brilhante D, Macêdo A, Cserti-Gazdewich C, Pendergrast JM, Hawes J, Lundgren MN, Storry JR, Jain A, Marwaha N, Sharma RR. Vox Sanguinis International Forum on typing and matching strategies in patients on anti-CD38 monoclonal therapy: summary. Vox Sang 2018; 113:492-498. [PMID: 29781081 DOI: 10.1111/vox.12653] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Affiliation(s)
- K M K de Vooght
- Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands
| | - M Lozano
- Department of Hemotherapy and Hemostasis, University Clinic Hospital, University of Barcelona, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Daniels G, Finning K, Lozano M, Hyland CA, Liew YW, Powley T, Castilho L, Bonet Bub C, Kutner JM, Banch Clausen F, Christiansen M, Sulin K, Haimila K, Legler TJ, Lambert M, Ryan H, Ní Loingsigh S, Matteocci A, Pierelli L, Dovc Drnovsek T, Bricl I, Nogués N, Muñiz-Diaz E, Olsson ML, Wikman A, de Haas M, van der Schoot CE, Massey E, Westhoff CM. Vox Sanguinis International Forum on application of fetal blood grouping: summary. Vox Sang 2017; 113:198-201. [DOI: 10.1111/vox.12616] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Affiliation(s)
| | - K. Finning
- International Blood Group Reference Lab; NHS Blood and Transplant; Northway, Filton Bristol BS34 7QH UK
| | - M. Lozano
- Department of Hemotherapy and Hemostasis; University Clinic Hospital; University of Barcelona; Barcelona Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Daniels G, Finning K, Lozano M, Hyland CA, Liew YW, Powley T, Castilho L, Bonet Bub C, Kutner JM, Banch Clausen F, Christiansen M, Sulin K, Haimila K, Legler TJ, Lambert M, Ryan H, Ní Loingsigh S, Matteocci A, Pierelli L, Dovc Drnovsek T, Bricl I, Nogués N, Muñiz-Diaz E, Olsson ML, Wikman A, de Haas M, van der Schoot CE, Massey E, Westhoff CM. Vox Sanguinis International Forum on application of fetal blood grouping. Vox Sang 2017; 113:e26-e35. [DOI: 10.1111/vox.12615] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
| | | | | | - C. A. Hyland
- Australian Red Cross Blood Service, Research and Development; 44 Musk Avenue, Kelvin Grove Brisbane Qld 4059 Australia
| | - Y.-W. Liew
- Australian Red Cross Blood Service, Research and Development; 44 Musk Avenue, Kelvin Grove Brisbane Qld 4059 Australia
| | - T. Powley
- Australian Red Cross Blood Service, Research and Development; 44 Musk Avenue, Kelvin Grove Brisbane Qld 4059 Australia
| | - L. Castilho
- Departamento de Hemoterapia; Hospital Israelita Albert Einstein; Avenida Albert Einstein, 627-3° andar Bloco E CEP: 05651-901 São Paulo SP Brazil
| | - C. Bonet Bub
- Departamento de Hemoterapia; Hospital Israelita Albert Einstein; Avenida Albert Einstein, 627-3° andar Bloco E CEP: 05651-901 São Paulo SP Brazil
| | - J. M. Kutner
- Departamento de Hemoterapia; Hospital Israelita Albert Einstein; Avenida Albert Einstein, 627-3° andar Bloco E CEP: 05651-901 São Paulo SP Brazil
| | - F. Banch Clausen
- Laboratory of Blood Genetics, Rigshospitalet, Section 2034, Department of Clinical Immunology; Copenhagen University Hospital; Blegdamsvej 9 Copenhagen Denmark
| | - M. Christiansen
- Department of Clinical Immunology; Aarhus University Hospital; Palle Juul-Jensens Boulevard 99 8200 Aarhus N Denmark
| | - K. Sulin
- Blood Group Unit; Finnish Red Cross Blood Service; Kivihaantie 7 FI-00310 Helsinki Finland
| | - K. Haimila
- Blood Group Unit; Finnish Red Cross Blood Service; Kivihaantie 7 FI-00310 Helsinki Finland
| | - T. J. Legler
- Department of Transfusion Medicine; University Medical Center Göttingen; Georg-August-Universität; Robert-Koch-Str. 40 Göttingen 37075 Germany
| | - M. Lambert
- Irish Blood Transfusion Service; Blood Group Genetics; National Blood Centre; James's Street Dublin 8 Ireland
| | - H. Ryan
- Irish Blood Transfusion Service; Blood Group Genetics; National Blood Centre; James's Street Dublin 8 Ireland
| | - S. Ní Loingsigh
- Irish Blood Transfusion Service; Blood Group Genetics; National Blood Centre; James's Street Dublin 8 Ireland
| | - A. Matteocci
- Department of Transfusion Medicine; San Camillo Forlanini Hospital; Circonvallazione Gianicolense 87 00152 Roma Italy
| | - L. Pierelli
- Department of Experimental Medicine; Sapienza University of Rome; Piazzale Aldo Moro 5 00185 Roma Italy
- Department of Transfusion Medicine; San Camillo Forlanini Hospital; Circonvallazione Gianicolense 87 00152 Roma Italy
| | - T. Dovc Drnovsek
- Department of Immunohematology; Blood Transfusion Centre of Slovenia; Slajmerjeva 6 SI-Ljubljana Slovenia
| | - I. Bricl
- Department of Immunohematology; Blood Transfusion Centre of Slovenia; Slajmerjeva 6 SI-Ljubljana Slovenia
| | - N. Nogués
- Immunohematology Department; Banc de Sang i Teixits; Passeig de Taulat 116 08005 Barcelona Spain
| | - E. Muñiz-Diaz
- Immunohematology Department; Banc de Sang i Teixits; Passeig de Taulat 116 08005 Barcelona Spain
| | - M. L. Olsson
- Department of Laboratory Medicine; Lund University; Lund Sweden
- Department of Clinical Immunology and Transfusion Medicine; LabMedicine; Office of Medical Services; Region Skåne Lund Sweden
| | - A. Wikman
- Department of Clinical Immunology and Transfusion Medicine; Karolinska University Hospital and Karolinska Institutet; Stockholm Sweden
| | - M. de Haas
- Sanquin Diagnostic Services; Department of Immunohematology Diagnostics; Sanquin Research; Plesmanlaan 125 1066 CX Amsterdam The Netherlands
- Center for Clinical Transfusion Research; Leiden The Netherlands
- Department of Immunohematology and Blood Transfusion; Leiden University Medical Center; Leiden The Netherlands
| | - C. E. van der Schoot
- Sanquin Research; Plesmanlaan 125 1066 CX Amsterdam The Netherlands
- Department of Experimental Immunohematology; Sanquin Research; Amsterdam The Netherlands
- Landsteiner Laboratory; Academic Medical Centre; University of Amsterdam; Amsterdam The Netherlands
| | - E. Massey
- Diagnostic and Therapeutic Services; NHS Blood and Transplant; North Bristol Park, Northway Filton Bristol BS34 7QH UK
| | - C. M. Westhoff
- Immunohematology and Genomics; New York Blood Center; 310 E 67th St New York NY 10065 USA
| |
Collapse
|
32
|
Datar I, Sanmamed M, Choi J, Wang J, Henick B, Badri T, Mejias L, Lozano M, Gracia J, Velcheti V, Herbst R, Melero I, Chen L, Schalper K. In patients with advanced non-small cell lung cancer (NSCLC) LAG-3 is expressed on activated TILs and predicts resistance to PD-1 axis blockers. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx710.006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
33
|
Martinez-Terroba E, Behrens C, De Miguel F, Agorreta J, Monsó E, Millares L, Mesa-Guzman M, Perez-Gracia J, Lozano M, Zulueta J, Pio R, Wistuba I, Pajares M, Montuenga L. P2.02-061 Two Novel Protein-Based Prognostic Signatures Improve Risk Stratification of Early Lung ADC and SCC Patients. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1239] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
34
|
Strunk D, Lozano M, Marks DC, Loh YS, Gstraunthaler G, Schennach H, Rohde E, Laner-Plamberger S, Öller M, Nystedt J, Lotfi R, Rojewski M, Schrezenmeier H, Bieback K, Schäfer R, Bakchoul T, Waidmann M, Jonsdottir-Buch SM, Montazeri H, Sigurjonsson OE, Iudicone P, Fioravanti D, Pierelli L, Introna M, Capelli C, Falanga A, Takanashi M, Lόpez-Villar O, Burnouf T, Reems JA, Pierce J, Preslar AM, Schallmoser K. International Forum on GMP-grade human platelet lysate for cell propagation: summary. Vox Sang 2017; 113:80-87. [PMID: 29076169 DOI: 10.1111/vox.12593] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Affiliation(s)
- D Strunk
- Institute of Experimental and Clinical Cell Therapy, Paracelsus Medical University, Salzburg, Austria
| | - M Lozano
- Hospital Clinic, Department of Hemotherapy and Hemostasis, Hospital Clínic University of Barcelona , Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - K Schallmoser
- Department of Blood Group Serology and Transfusion Medicine, Paracelsus Medical University Hospital Salzburg, Salzburg, Austria
| |
Collapse
|
35
|
Strunk D, Lozano M, Marks DC, Loh YS, Gstraunthaler G, Schennach H, Rohde E, Laner-Plamberger S, Öller M, Nystedt J, Lotfi R, Rojewski M, Schrezenmeier H, Bieback K, Schäfer R, Bakchoul T, Waidmann M, Jonsdottir-Buch SM, Montazeri H, Sigurjonsson OE, Iudicone P, Fioravanti D, Pierelli L, Introna M, Capelli C, Falanga A, Takanashi M, López-Villar O, Burnouf T, Reems JA, Pierce J, Preslar AM, Schallmoser K. International Forum on GMP-grade human platelet lysate for cell propagation. Vox Sang 2017; 113:e1-e25. [PMID: 29071726 DOI: 10.1111/vox.12594] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Affiliation(s)
| | | | - D C Marks
- Australian Red Cross Blood Service, Research and Development, 17 O'Riordan Street, Sydney, New South Wales, 2015, Australia
| | - Y S Loh
- Australian Red Cross Blood Service, Research and Development, 17 O'Riordan Street, Sydney, New South Wales, 2015, Australia
| | - G Gstraunthaler
- Division of Physiology, Medical University Innsbruck, Schöpfstr. 41, Innsbruck, A-6020, Austria
| | - H Schennach
- Central Institute of Blood Transfusion and Immunology, University Hospital Innsbruck, Anichstr. 35, Innsbruck, A-6020, Austria
| | - E Rohde
- Department of Blood Group Serology and Transfusion Medicine, Spinal Cord Injury and Tissue Regeneration Center Salzburg, Paracelsus Medical University, Lindhofstrasse 20-22, Salzburg, 5020, Austria
| | - S Laner-Plamberger
- Department of Blood Group Serology and Transfusion Medicine, Spinal Cord Injury and Tissue Regeneration Center Salzburg, Paracelsus Medical University, Lindhofstrasse 20-22, Salzburg, 5020, Austria
| | - M Öller
- Department of Blood Group Serology and Transfusion Medicine, Spinal Cord Injury and Tissue Regeneration Center Salzburg, Paracelsus Medical University, Lindhofstrasse 20-22, Salzburg, 5020, Austria
| | - J Nystedt
- Finnish Red Cross Blood Service, Advanced Cell Therapy Centre, Kivihaantie 7, FI-00310, Helsinki, Finland
| | - R Lotfi
- Institute for Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Service, Baden-Wuerttemberg-Hessen , University Hospital Ulm, University of Ulm, Helmholtzstr. 10, Ulm, 89081, Germany
| | - M Rojewski
- Institute for Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Service, Baden-Wuerttemberg-Hessen , University Hospital Ulm, University of Ulm, Helmholtzstr. 10, Ulm, 89081, Germany
| | - H Schrezenmeier
- Institute for Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Service, Baden-Wuerttemberg-Hessen , University Hospital Ulm, University of Ulm, Helmholtzstr. 10, Ulm, 89081, Germany
| | - K Bieback
- Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, German Red Cross Blood Service Baden-Württemberg - Hessen, Heidelberg University, Friedrich-Ebert Str. 107, Mannheim, D-68167, Germany
| | - R Schäfer
- Institute for Transfusion Medicine and Immunohematology, German Red Cross Blood Donor Service Baden-Württemberg- Hessen gGmbH, Goethe-University Hospital, Sandhofstrasse 1, Frankfurt am Main, D-60528, Germany
| | - T Bakchoul
- Center for Clinical Transfusion Medicine, Otfried-Müller-Strasse 4/1, D-72076 , Tuebingen, Germany
| | - M Waidmann
- Center for Clinical Transfusion Medicine, Otfried-Müller-Strasse 4/1, D-72076 , Tuebingen, Germany
| | - S M Jonsdottir-Buch
- The Blood Bank, Landspitali University Hospital, Snorrabraut 60, 101, Reykjavik, Iceland.,Faculty of Medicine, University of Iceland, Vatnsmyrarvegur 16, 101, Reykjavik, Iceland.,Platome Biotechnology, Alfaskeid 27, 220, Hafnarfjordur, Iceland
| | - H Montazeri
- The Blood Bank, Landspitali University Hospital, Snorrabraut 60, 101, Reykjavik, Iceland.,Platome Biotechnology, Alfaskeid 27, 220, Hafnarfjordur, Iceland
| | - O E Sigurjonsson
- The Blood Bank, Landspitali University Hospital, Snorrabraut 60, 101, Reykjavik, Iceland.,Platome Biotechnology, Alfaskeid 27, 220, Hafnarfjordur, Iceland.,School of Science and Engineering, University of Reykjavik, Menntavegur 1, 101, Reykjavik, Iceland
| | - P Iudicone
- San Camillo Forlanini Hospital, Circonvallazione Gianicolense 87, Rome, 00152, Italy
| | - D Fioravanti
- San Camillo Forlanini Hospital, Circonvallazione Gianicolense 87, Rome, 00152, Italy
| | - L Pierelli
- Department of Experimental Medicine, Sapienza University, Piazzale Aldo Moro 5, Rome, 00185, Italy
| | - M Introna
- QP USS Centro di Terapia Cellulare 'G. Lanzani', USC Ematologia, ASST Papa Giovanni XXIII, Via Garibaldi 11/13, Bergamo, 24124, Italy
| | - C Capelli
- USS Centro di Terapia Cellulare 'G. Lanzani', USC Ematologia, ASST Papa Giovanni XXIII, Via Garibaldi 11/13, Bergamo, 24124, Italy
| | - A Falanga
- Division of Immunohematology and Transfusion Medicine, ASST Papa Giovanni XXIII, Piazza OMS 1, Bergamo, 24127, Italy
| | - M Takanashi
- Japanese Red Cross Blood Service Headquarters, 1-2-1 Shiba-koen, Minato-ku, Tokyo, 105-0011, Japan
| | - O López-Villar
- Department of Hematology, University Hospital of Salamanca, P/San Vicente 58-182, Salamanca, 37007, Spain
| | - T Burnouf
- Graduate Institute of Biomedical Materials and Tissue Engineering, International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, 250 Wu-Shin Street, Taipei, 101, Taiwan
| | - J A Reems
- Division of Hematology and Hematologic Malignancies, Department of Medicine, University of Utah Cell Therapy and Regenerative Medicine, 675 Arapeen, Suite 300, Salt Lake City, Utah, 84108, USA
| | - J Pierce
- Division of Hematology and Hematologic Malignancies, Department of Medicine, University of Utah Cell Therapy and Regenerative Medicine, 675 Arapeen, Suite 300, Salt Lake City, Utah, 84108, USA
| | - A M Preslar
- Division of Hematology and Hematologic Malignancies, Department of Medicine, University of Utah Cell Therapy and Regenerative Medicine, 675 Arapeen, Suite 300, Salt Lake City, Utah, 84108, USA
| | | |
Collapse
|
36
|
Cohn C, Dumont L, Lozano M, Marks D, Johnson L, Ismay S, Bondar N, T'Sas F, Yokoyama A, Kutner J, Acker J, Bohonek M, Sailliol A, Martinaud C, Pogłód R, Antoniewicz-Papis J, Lachert E, Pun P, Lu J, Cid J, Guijarro F, Puig L, Gerber B, Alberio L, Schanz U, Buser A, Noorman F, Zoodsma M, van der Meer P, de Korte D, Wagner S, O'Neill M. Vox Sanguinis International Forum on platelet cryopreservation. Vox Sang 2017; 112:e69-e85. [DOI: 10.1111/vox.12532] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Affiliation(s)
| | | | | | - D.C. Marks
- Australian Red Cross Blood Service; 17 O'Riordan Street Alexandria NSW 2015 Australia
| | - L. Johnson
- Australian Red Cross Blood Service; 17 O'Riordan Street Alexandria NSW 2015 Australia
| | - S. Ismay
- Australian Red Cross Blood Service; 17 O'Riordan Street Alexandria NSW 2015 Australia
| | - N. Bondar
- Australian Red Cross Blood Service; 17 O'Riordan Street Alexandria NSW 2015 Australia
| | - F. T'Sas
- HMRA - Service Militaire de Transfusion Sanguine; Rue Bruyn 1 1120 Bruxelles Belgique
| | - A.P.H. Yokoyama
- Departamento de Hemoterapia; Hospital Israelita Albert Einstein; Av. Albert Einstein, 627 Sao Paulo SP 05651-901 Brazil
| | - J.M. Kutner
- Departamento de Hemoterapia; Hospital Israelita Albert Einstein; Av. Albert Einstein, 627 Sao Paulo SP 05651-901 Brazil
| | - J.P. Acker
- Canadian Blood Services; 8249-114 Street Edmonton AB T6G 2R8 Canada
| | - M. Bohonek
- Department of Hematology and Blood Transfusion; Military University Hospital Prague; U Vojenske nemocnice 1200 Prague 169 02 Czech Republic
| | - A. Sailliol
- French Military Blood Institute; 1 rue de Lieutenant Batany Clamart 92140 France
| | - C. Martinaud
- French Military Blood Institute; 1 rue de Lieutenant Batany Clamart 92140 France
| | - R. Pogłód
- Zakład Transfuzjologii; Instytut Hematologii i Transfuzjologii; ul. I. Gandhi 14 Warszawa 02-776 Poland
| | - J. Antoniewicz-Papis
- Institute of Hematology and Transfusion Medicine; Indiry Gandhi 14 Warsaw 02-776 Poland
| | - E. Lachert
- Institute of Hematology and Transfusion Medicine; Indiry Gandhi 14 Warsaw 02-776 Poland
| | - P.B.L. Pun
- Defence Medical & Environmental Research Institute; DSO National Laboratories (Kent Ridge); 27 Medical Drive Singapore 117510
| | - J. Lu
- Defence Medical & Environmental Research Institute; DSO National Laboratories (Kent Ridge); 27 Medical Drive Singapore 117510
| | - J. Cid
- Apheresis Unit; Department of Hemotherapy and Hemostasis; ICMHO; Hospital Clínic; Villarroel 170 Barcelona Catalonia 08036 Spain
| | - F. Guijarro
- Apheresis Unit; Department of Hemotherapy and Hemostasis; ICMHO; IDIBAPS; Hospital Clínic; University of Barcelona; Barcelona Spain
| | - L. Puig
- Banc de Sang i Teixits de Catalunya; Transfusion Safety Laboratory; Barcelona Spain
| | - B. Gerber
- Division of Hematology; Oncology Institute of Southern Switzerland; Bellinzona CH-6500 Switzerland
| | - L. Alberio
- Division of Hematology and Central Hematology Laboratory; CHUV; Lausanne University Hospital; Lausanne Switzerland
| | - U. Schanz
- Division of Hematology; University and University Hospital Zurich; Zurich Switzerland
| | - A. Buser
- Hematology; University Hospital Basel; Basel Switzerland
| | - F. Noorman
- Military Blood Bank; Plesmanlaan 1c 2333 BZ The Netherlands
| | - M. Zoodsma
- Military Blood Bank; Plesmanlaan 1c 2333 BZ The Netherlands
| | - P.F. van der Meer
- Department of Product and Process Development; Sanquin Blood Bank; Plesmanlaan 125 Amsterdam 1066 CX The Netherlands
| | - D. de Korte
- Sanquin Blood Bank North West Region; Plesmanlaan 125 Amsterdam 1066 CX The Netherlands
| | - S. Wagner
- Transfusion Innovation Dept.; American Red Cross Holland Lab; 15601 Crabbs Branch Way Rockville MD 20855 USA
| | - M. O'Neill
- American Red Cross Medical Office; 180 Rustcraft Rd Dedham MA 020206 USA
| |
Collapse
|
37
|
Cohn CS, Dumont LJ, Lozano M, Marks DC, Johnson L, Ismay S, Bondar N, T'Sas F, Yokoyama APH, Kutner JM, Acker JP, Bohonek M, Sailliol A, Martinaud C, Pogłód R, Antoniewicz-Papis J, Lachert E, Pun PBL, Lu J, Cid J, Guijarro F, Puig L, Gerber B, Alberio L, Schanz U, Buser A, Noorman F, Zoodsma M, van der Meer PF, de Korte D, Wagner S, O'Neill M. Vox Sanguinis International Forum on platelet cryopreservation: Summary. Vox Sang 2017; 112:684-688. [PMID: 28929502 DOI: 10.1111/vox.12533] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- C S Cohn
- Department of Laboratory Medicine and Pathology, University of Minnesota, D242 Mayo Building, MMC 609, 420 Delaware Street SE, Minneapolis, MN, 55455, USA
| | - L J Dumont
- Blood Systems Research Institute Denver, 717 Yosemite Street, Denver, CO, 80230, USA
| | - M Lozano
- Department of Hemotherapy and Hemostasis, University Clinic Hospital, University of Barcelona, 08036, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Morton S, Stanworth S, Lozano M, Harrison S, Hong F, Dennington P, McQuilten Z, Worel N, Compernolle V, Kutner J, Yokoyama A, Nahirniak S, Germain M, Hume H, Robitaille N, Wilson A, Tinmouth A, Massey E, Boulat C, Woimant G, Tiberghien P, Schulze TJ, Bux J, Pierelli L, Ballester C, Netelenbos T, West KA, Conry-Cantilena C, Eder A, Haley NR, Yazer M, Triulzi D. Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use. Vox Sang 2017; 112:e48-e68. [DOI: 10.1111/vox.12523] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- S. Morton
- NHS Blood and Transplant; University Hospitals Birmingham NHS Foundation Trust; Birmingham UK
| | - S. Stanworth
- NHS Blood and Transplant; Oxford University Hospital NHS Foundation Trust; Oxford UK
| | | | - S.J. Harrison
- Peter MacCallum Cancer Centre; Melbourne Vic. Australia
- Victoria Comprehensive Cancer Centre, Grattan Street; Melbourne Vic. 3000 Australia
- Sir Peter MacCallum Department of Oncology; Melbourne University; Melbourne Vic. 3000 Australia
| | - F.S. Hong
- Clinical Services and Research; Australian Red Cross Blood Service; 100 Batman St West Melbourne Vic. 3003 Australia
| | - P. Dennington
- Clinical Services and Research; Australian Red Cross Blood Service; 17 O'Riordan Street Alexandria NSW 2015 Australia
| | - Z. McQuilten
- Department of Epidemiology and Preventive Medicine; Monash University; Level 6, 99 Commercial Road Melbourne Vic. 3001 Australia
| | - N. Worel
- Department of Blood Group Serology and Transfusion Medicine; Medical University Vienna; Waehringer Guertel 18-20 A-1090 Vienna Austria
| | - V. Compernolle
- Belgian Red Cross-Flanders; Blood Services; Ottergemsesteenweg 413 B-9000 Ghent Belgium
| | - J.M. Kutner
- Hospital Israelita Albert Einstein; Av. Albert Einstein, 627 - Banco de Sangue 05651-901 Sao Paulo SP Brazil
| | - A.P.H. Yokoyama
- Hospital Israelita Albert Einstein; Av. Albert Einstein, 627 - Banco de Sangue 05651-901 Sao Paulo SP Brazil
| | - S. Nahirniak
- Department of Laboratory Medicine and Pathology; University of Alberta; 4B1.23 WMC 8440-112 St. Edmonton AB T6G 2B7 Canada
| | - M. Germain
- Medical Affairs; Héma-Québec; 1070 Sciences-de-la-Vie Ave Québec QC G1V 5C3 Canada
| | - H. Hume
- Département de Pédiatrie; Université de Montréal Service d'Hématologie/Oncologie; CHU Sainte-Justine 3175 Côte-Sainte-Catherine Montréal QC H3T 1C5 Canada
| | - N. Robitaille
- Département de Pédiatrie; Université de Montréal Service d'Hématologie/Oncologie; CHU Sainte-Justine 3175 Côte-Sainte-Catherine Montréal QC H3T 1C5 Canada
| | - A. Wilson
- Department of Hematology; McGill University Health Centre; 1001 Boul. Décarie Montréal QC Canada
| | - A. Tinmouth
- Benign Hematology and Transfusion Medicine; Ottawa Hospital and Ottawa Hospital Research Institute; 501 Smyth Rd Box 201a Ottawa ON K1H 8L6 Canada
| | - E. Massey
- Benign Hematology and Transfusion Medicine; Ottawa Hospital and Ottawa Hospital Research Institute; 501 Smyth Rd Box 201a Ottawa ON K1H 8L6 Canada
| | - C. Boulat
- Etablissement Français du Sang; 20 Avenue du Stade de France 93218 La Plaine St Denis Cedex France
| | - G. Woimant
- Etablissement Français du Sang; 20 Avenue du Stade de France 93218 La Plaine St Denis Cedex France
| | - P. Tiberghien
- Etablissement Français du Sang; 20 Avenue du Stade de France 93218 La Plaine St Denis Cedex France
| | - T. J. Schulze
- Institute of Transfusion Medicine and Immunology; Medical Faculty Mannheim; Heidelberg University; German Red Cross Blood Service Baden-Württemberg - Hessen Friedrich-Ebert-Str. 107 68167 Mannheim Germany
| | - J. Bux
- University of Bochum; Linnenkamp 19 Hagen 58093 Germany
| | - L. Pierelli
- Transfusion Medicine and Stem Cells; San Camillo Forlanini Hospital; Circonvallazione Gianicolense 87 00152 Rome Italy
| | - C. Ballester
- Department Hematology and Hemotherapy; Son Espases University Hospital; Carretera de Valldemossa 79 07010 Palma de Mallorca Spain
| | - T. Netelenbos
- Internist-hematologist and transfusion specialist; Department of Immunohematology and Blood Transfusion, E3Q; Leids University Medical Center; Postbus 9600 2300RC Leiden The Netherlands
| | - K. A. West
- Department of Transfusion Medicine; National Institutes of Health Clinical Center; 10 Center Drive Room 1N226 Bethesda MD 20892 USA
| | - C. Conry-Cantilena
- Blood Services Section; NIH/CC/DTM; Building 10 Room 1C711 Bethesda MD 20892 USA
| | - A. Eder
- Blood Services Section; NIH/CC/DTM; Building 10 Room 1C711 Bethesda MD 20892 USA
| | - N. R. Haley
- Bloodworks Northwest; Medical Services; 921 Terry Avenue Seattle WA 98104 USA
| | - M. Yazer
- University of Pittsburgh; Pittsburgh; PA USA
- University of Southern Denmark; Odense Denmark
| | - D. Triulzi
- Division of Transfusion Medicine; Department of Pathology; University of Pittsburgh Pittsburgh PA USA
| |
Collapse
|
39
|
Morton S, Stanworth S, Lozano M, Harrison S, Hong F, Dennington P, McQuilten Z, Worel N, Compernolle V, Kutner J, Yokoyama A, Nahirniak S, Germain M, Hume H, Robitaille N, Wilson A, Tinmouth A, Massey E, Boulat C, Woimant G, Tiberghien P, Schulze T, Bux J, Pierelli L, Ballester C, Netelenbos T, West K, Conry-Cantilena C, Eder A, Haley N, Yazer M, Triulzi D. Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use: summary. Vox Sang 2017; 112:680-683. [DOI: 10.1111/vox.12522] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- S. Morton
- NHS Blood and Transplant; University Hospitals Birmingham NHS Foundation Trust; Vicent Drive Edgbaston Birmingham B15 2SG UK
| | - S. Stanworth
- NHSBT/Oxford University Hospital NHS Foundation Trust; Radcliffe Department of Medicine; John Radcliffe Hospital; University of Oxford; Headington, Oxford OX3 9BQ UK
| | - M. Lozano
- Department of Hemotherapy and Hemostasis; University Clinic Hospital; University of Barcelona; Villarroel 170 08036 Barcelona Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Dupont E, Otuka N, Cabellos O, Aberle O, Aerts G, Altstadt S, Alvarez H, Alvarez-Velarde F, Andriamonje S, Andrzejewski J, Audouin L, Bacak M, Badurek G, Balibrea J, Barbagallo M, Barros S, Baumann P, Bécares V, Bečvář F, Beinrucker C, Belloni F, Berthier B, Berthoumieux E, Billowes J, Boccone V, Bosnar D, Brown A, Brugger M, Caamaño M, Calviani M, Calviño F, Cano-Ott D, Capote R, Cardella R, Carrapiço C, Casanovas A, Castelluccio D, Cennini P, Cerutti F, Chen Y, Chiaveri E, Chin M, Colonna N, Cortés G, Cortés-Giraldo M, Cosentino L, Couture A, Cox J, Damone L, David S, Deo K, Diakaki M, Dillmann I, Domingo-Pardo C, Dressler R, Dridi W, Duran I, Eleftheriadis C, Embid-Segura M, Fernández-Domínguez B, Ferrant L, Ferrari A, Ferreira P, Finocchiaro P, Fraval K, Frost R, Fujii K, Furman W, Ganesan S, Garcia A, Gawlik A, Gheorghe I, Gilardoni S, Giubrone G, Glodariu T, Göbel K, Gomez-Hornillos M, Goncalves I, Gonzalez-Romero E, Goverdovski A, Gramegna F, Griesmayer E, Guerrero C, Gunsing F, Gurusamy P, Haight R, Harada H, Heftrich T, Heil M, Heinitz S, Hernández-Prieto A, Heyse J, Igashira M, Isaev S, Jenkins D, Jericha E, Kadi Y, Kaeppeler F, Kalamara A, Karadimos D, Karamanis D, Katabuchi T, Kavrigin P, Kerveno M, Ketlerov V, Khryachkov V, Kimura A, Kivel N, Kokkoris M, Konovalov V, Krtička M, Kroll J, Kurtulgil D, Lampoudis C, Langer C, Leal-Cidoncha E, Lederer C, Leeb H, Naour CL, Lerendegui-Marco J, Leong L, Licata M, Meo SL, Lonsdale S, Losito R, Lozano M, Macina D, Manousos A, Marganiec J, Martinez T, Marrone S, Masi A, Massimi C, Mastinu P, Mastromarco M, Matteucci F, Maugeri E, Mazzone A, Mendoza E, Mengoni A, Milazzo P, Mingrone F, Mirea M, Mondelaers W, Montesano S, Moreau C, Mosconi M, Musumarra A, Negret A, Nolte R, O’Brien S, Oprea A, Palomo-Pinto F, Pancin J, Paradela C, Patronis N, Pavlik A, Pavlopoulos P, Perkowski J, Perrot L, Pigni M, Plag R, Plompen A, Plukis L, Poch A, Porras I, Praena J, Pretel C, Quesada J, Radeck D, Rajeev K, Rauscher T, Reifarth R, Riego A, Robles M, Roman F, Rout P, Rudolf G, Rubbia C, Rullhusen P, Ryan J, Sabaté-Gilarte M, Salgado J, Santos C, Sarchiapone L, Sarmento R, Saxena A, Schillebeeckx P, Schmidt S, Schumann D, Sedyshev P, Smith A, Sosnin N, Stamatopoulos A, Stephan C, Suryanarayana S, Tagliente G, Tain J, Tarifeño-Saldivia A, Tarrío D, Tassan-Got L, Tavora L, Terlizzi R, Tsinganis A, Valenta S, Vannini G, Variale V, Vaz P, Ventura A, Versaci R, Vermeulen M, Villamarin D, Vicente M, Vlachoudis V, Vlastou R, Voss F, Wallner A, Walter S, Ware T, Warren S, Weigand M, Weiß C, Wolf C, Wiesher M, Wisshak K, Woods P, Wright T, Žugec P. Dissemination of data measured at the CERN n_TOF facility. EPJ Web Conf 2017. [DOI: 10.1051/epjconf/201714607002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
41
|
Muñoz-Gómez R, Rincón D, Ahumada A, Hernández E, Devesa MJ, Izquierdo S, Ortiz M, Hernández-Albujar A, Fernández-Rodríguez C, Calvo M, González R, Lozano M, Castellano G, Fernández-Vázquez I. Therapy with ombitasvir/paritaprevir/ritonavir plus dasabuvir is effective and safe for the treatment of genotypes 1 and 4 hepatitis C virus (HCV) infection in patients with severe renal impairment: A multicentre experience. J Viral Hepat 2017; 24:464-471. [PMID: 27976490 DOI: 10.1111/jvh.12664] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/16/2016] [Accepted: 11/28/2016] [Indexed: 12/16/2022]
Abstract
Limited data are available on direct-acting antivirals for treating hepatitis C virus (HCV) infection in patients with severe renal impairment. The aim of this study was to evaluate the effectiveness and safety of ombitasvir/paritaprevir/ritonavir (OBV/PTV/r) ± dasabuvir (DSV) ± ribavirin (RBV) in patients with stage 4 or 5 chronic kidney disease (CKD) and HCV genotype 1 or 4 infection in real clinical practice, and to investigate pharmacological interactions. This retrospective study included patients treated with OBV/PTV/r+DSV±RBV or OBV/PTV/r+RBV with CKD stage 4 (eGFR: 15-29 mL/min/1.73m2 ) or 5 (eGFR<15 mL/min/1.73m2 or requiring dialysis) and HCV infection by genotypes 1 and 4 between April 2015 and October 2015 in nine Spanish centres. Sustained virological response at 12 weeks (SVR12) was assessed, and clinical and laboratory data, fibrosis stage, adverse events and pharmacological interactions were reported. Forty-six patients were included: 10 (21.7%) had CKD stage 4 and 36 (78.2%) CKD stage 5. Seventeen (36.9%) had cirrhosis. SVR12 rate in the intention-to-treat population was 95.7%. Twenty-one (45.6%) received RBV, which was discontinued in two (9.5%) patients. Anaemia (haemoglobin <10 g/dl) occurred in 12 patients (57.1%) with RBV vs 10 (40.0%) without RBV (P=.246). Renal function remained stable during antiviral therapy. Nine patients (19.5%) experienced serious adverse events unrelated to antiviral therapy. Concomitant medication was discontinued or modified in 41.3% of patients. In conclusion, the effectiveness of OBV/PTV/r±DSV±RBV in patients with CKD 4-5 was similar to that observed in those with normal renal function and was not associated with severe adverse events.
Collapse
Affiliation(s)
- R Muñoz-Gómez
- Department of Gastroenterology, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - D Rincón
- Unit of Hepatology, Hospital Universitario Gregorio Marañón, CIBERehd , Madrid, Spain
| | - A Ahumada
- Unit of Hepatology, Hospital Universitario Gregorio Marañón, CIBERehd , Madrid, Spain
| | - E Hernández
- Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - M J Devesa
- Department of Gastroenterology, Hospital Universitario Clínico San Carlos, Madrid, Spain
| | - S Izquierdo
- Department of Gastroenterology, Hospital Universitario Clínico San Carlos, Madrid, Spain
| | - M Ortiz
- Department of Gastroenterology, Hospital Universitario Infanta Cristina, Madrid, Spain
| | - A Hernández-Albujar
- Department of Gastroenterology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain
| | - C Fernández-Rodríguez
- Department of Gastroenterology, Hospital Universitario Fundación Alcorcón, Madrid, Spain
| | - M Calvo
- Department of Gastroenterology, Complejo Asistencial de Segovia, Segovia, Spain
| | - R González
- Department of Gastroenterology, Hospital Universitario del Sureste, Madrid, Spain
| | - M Lozano
- Department of Gastroenterology, Hospital Universitario Infanta Leonor, Madrid, Spain
| | - G Castellano
- Department of Gastroenterology, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - I Fernández-Vázquez
- Department of Gastroenterology, Hospital Universitario 12 de Octubre, Madrid, Spain
| |
Collapse
|
42
|
Lozano M, Ramada JM, Peiró J, Frígola A, Esteve MJ. Dietary Assesment of Free-Living Elderly Spanish People with Disabilities. Ecol Food Nutr 2017; 56:277-296. [PMID: 28548585 DOI: 10.1080/03670244.2017.1323742] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
Nutritional research in elderly disabled is difficult in noninstitutionalized people. The dietary intake of a noninstitutionalized disabled population of the eastern region of Spain was evaluated to detect possible nutritional deviations. A total of 329 participants aged 65 and over were recruited. Most participants were overweight. Carbohydrates did not reach 50% of total Kcal/day. Insufficient micronutrient intakes and high consumption of simple carbohydrates and saturated fats (SFA) were found. A decreasing trend of water intake (p < .05) as well as an increasing trend of alcohol consumption (p < .05) with increasing age was found. The area of residence had a relevant impact on nutritional, dietary, and anthropometric characteristics of our population.
Collapse
Affiliation(s)
- M Lozano
- a Department of Preventive Medicine and Public Health, Food Sciences, Toxicology, and Legal Medicine , University of Valencia , Burjassot , Spain
| | - J M Ramada
- b Institut Hospital del Mar d'Investigacions Mèdiques (IMIM) , Barcelona , Spain.,c CIBER de Epidemiologìa y Salud Pública (CIBERESP) , Madrid , Spain
| | - J Peiró
- d Department of Statistics and Operations Research , University of Valencia , Burjassot , Spain
| | - A Frígola
- a Department of Preventive Medicine and Public Health, Food Sciences, Toxicology, and Legal Medicine , University of Valencia , Burjassot , Spain
| | - M J Esteve
- a Department of Preventive Medicine and Public Health, Food Sciences, Toxicology, and Legal Medicine , University of Valencia , Burjassot , Spain
| |
Collapse
|
43
|
Yazer MH, van de Watering L, Lozano M, Sirdesai S, Rushford K, Wood EM, Yokoyama AP, Kutner JM, Lin Y, Callum J, Cserti-Gazdewich C, Lieberman L, Pendergrast J, Pendry K, Murphy MF, Selleng K, Greinacher A, Marwaha N, Sharma R, Jain A, Orlin Y, Yahalom V, Perseghin P, Incontri A, Masera N, Okazaki H, Ikeda T, Nagura Y, Zwaginga JJ, Pogłod R, Rosiek A, Letowska M, Yuen J, Cid J, Harm SK, Adhikari P. Development of RBC transfusion indications and the collection of patient-specific pre-transfusion information. Vox Sang 2017; 112:e22-e47. [PMID: 28524359 DOI: 10.1111/vox.12509] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
| | | | | | - S Sirdesai
- Department of Clinical Haematology, Monash Health, Melbourne, Victoria, Australia
| | - K Rushford
- Monash Pathology, Monash Health, Melbourne, Victoria, Australia
| | - E M Wood
- Department of Clinical Haematology Monash Health and Transfusion Research Unit, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
| | - A P Yokoyama
- Hemotherapy and Cell Therapy Department, Hospital Israelita Albert Einstein, Av. Albert Einstein, 627 - Bloco E, São Paulo, SP, 05651-901, Brazil
| | - J M Kutner
- Hemotherapy and Cell Therapy Department, Hospital Israelita Albert Einstein, Av. Albert Einstein, 627 - Bloco E, São Paulo, SP, 05651-901, Brazil
| | - Y Lin
- Department of Clinical Pathology, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Room B2-04, Toronto, ON, Canada.,Department of Laboratory Medicine and Pathobiology, University of Toronto, 2075 Bayview Avenue, Room B2-04, Toronto, ON, M4N 3M5, Canada
| | - J Callum
- Department of Clinical Pathology, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Room B2-04, Toronto, ON, Canada
| | - C Cserti-Gazdewich
- Department of Medicine / Laboratory Medicine & Pathobiology, University of Toronto, Toronto General Hospital 3EC-306, 200 Elizabeth Street, Toronto, ON, Canada, M5G-2C4.,Laboratory Medicine Program, Laboratory Hematology: Blood Transfusion Laboratory, University Health Network, Toronto General Hospital 3EC-306, 200 Elizabeth Street, Toronto, ON, Canada, M5G-2C4
| | - L Lieberman
- Department of Laboratory Hematology (Transfusion Medicine), University Health Network, 200 Elizabeth Street, Suite 306, Toronto, ON, Canada, M5G 2C4
| | - J Pendergrast
- Department of Laboratory Hematology (Transfusion Medicine), University Health Network, 200 Elizabeth Street, Suite 306, Toronto, ON, Canada, M5G 2C4
| | - K Pendry
- Central Manchester University Hospitals, NHS Foundation Trust, Oxford Rd, Manchester, M13 9WL.,NHS Blood and Transplant Manchester Blood Centre, Plymouth Grove, Manchester, M13 9LL, UK
| | - M F Murphy
- Blood Transfusion Medicine, University of Oxford, Headley Way, Headington, Oxford, OX3 9BQ, UK.,NHS Blood andTransplant and Oxford University Hospitals NHS Foundation Trust, Headley Way, Headington, Oxford, OX3 9BQ, UK.,NHS Blood & Transplant, John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9BQ, UK
| | - K Selleng
- Institut für Immunologie und Transfusionsmedizin, Universitätsmedizin Greifswald, Sauerbruchstrasse, 17475, Greifswald, Germany
| | - A Greinacher
- Institut für Immunologie und Transfusionsmedizin, Universitätsmedizin Greifswald, Sauerbruchstrasse, 17475, Greifswald, Germany
| | - N Marwaha
- Department of Transfusion Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India
| | - R Sharma
- Department of Transfusion Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India
| | - A Jain
- Department of Transfusion Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India
| | - Y Orlin
- Transfusion & Apheresis Services, Rabin Medical Center, Petach Tikva, Israel
| | - V Yahalom
- Transfusion & Apheresis Services, Rabin Medical Center, Petach Tikva, Israel
| | - P Perseghin
- UOS Aferesi e nuove tecnologie trasfusionali-Laboratorio di Criobiologia, ASST-Monza Ospedale San Gerardo, Via Pergolesi 33, Monza (MB), 20900, Italy
| | - A Incontri
- UOS Aferesi e nuove tecnologie trasfusionali, ASST-Monza Ospedale San Gerardo, Via Pergolesi 33, Monza (MB), 20900, Italy
| | - N Masera
- Clinica Pediatrica, Università di Milano Bicocca and A. O. San Gerardo, Via Pergolesi 33, Monza (MB), 20900, Italy
| | - H Okazaki
- Department of Blood Transfusion, The University of Tokyo Hospital, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
| | - T Ikeda
- Department of Blood Transfusion, The University of Tokyo Hospital, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
| | - Y Nagura
- Department of Blood Transfusion, The University of Tokyo Hospital, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
| | - J J Zwaginga
- Department of Immunohematology and Bloodtransfusion, Center for Stem Cell Therapies, Leiden University Medical Center, Albinusdreef 2, Building 1, E3-Q P.O. Box 9600, 2300, RC Leiden, The Netherlands
| | - R Pogłod
- Department of Transfusion Medicine, Institute of Hematology and Transfusion Medicine, ul. Indira Gandhi 14, Warsaw, 02-776, Poland
| | - A Rosiek
- Department for Quality Assurance and Organization of Blood Transfusion Service, Institute of Hematology and Transfusion Medicine, ul. Indira Gandhi 14, Warsaw, 02-776, Poland
| | - M Letowska
- Department for Diagnostics for Hematology and Transfusion Service, Institute of Hematology and Transfusion Medicine, ul. Indira Gandhi 14, Warsaw, 02-776, Poland
| | - J Yuen
- Blood Transfusion Services, Department of Laboratory Medicine, Tan Tock Seng Hospital, Level 2 - Podium Block, 11 Jalan Tan Tock Seng, 308433, Singapore
| | - J Cid
- Apheresis Unit, Department of Hemotherapy and Hemostasis, Hospital Clínic, Villarroel 170, 08036 Barcelona, Catalonia, Spain
| | - S K Harm
- University of Vermont Medical Center, 111 Colchester Avenue, Burlington, VT, 05401, USA
| | - P Adhikari
- University of Vermont Medical Center, 111 Colchester Avenue, Burlington, VT, 05401, USA
| |
Collapse
|
44
|
Yazer MH, van de Watering L, Lozano M, Sirdesai S, Rushford K, Wood EM, Yokoyama AP, Kutner JM, Lin Y, Callum J, Cserti-Gazdewich C, Lieberman L, Pendergrast J, Pendry K, Murphy MF, Selleng K, Greinacher A, Marwaha N, Sharma R, Jain A, Orlin Y, Yahalom V, Perseghin P, Incontri A, Masera N, Okazaki H, Ikeda T, Nagura Y, Zwaginga JJ, Pogłod R, Rosiek A, Letowska M, Yuen J, Cid J, Harm SK, Adhikari P. Development of RBC transfusion indications and the collection of patient-specific pre-transfusion information: summary. Vox Sang 2017; 112:487-494. [PMID: 28524235 DOI: 10.1111/vox.12496] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Affiliation(s)
- M H Yazer
- The Institute for Transfusion Medicine, University of Pittsburgh and University of Southern Denmark, 3636 Blvd of the Allies, Pittsburgh, PA, 15213, USA
| | - L van de Watering
- Jon J van Rood Center for Clinical Transfusion Research, Sanquin - LUMC, Plesmaniaan 1a, Leiden, 2333 BZ, the Netherlands
| | - M Lozano
- Department of Hemotherapy and Hemostasis, University Clinic Hospital, Villaroel 170, Barcelona, 08036, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Sharma RR, Lozano M, Fearon M, Bigham M, Djoudi R, Gallian P, Woimant G, Lee C, Leung JNS, Tsoi WC, Marwaha N, Sachdev S, Tadokoro K, Tani Y, Matsukura H, Shantseva N, Zhiburt E, Hindawi S, Chay J, Huang T, Teo D, Moleli N, Oyonarte S, Jayasekara SBA, Bokhorst A, van den Burg P, Hewitt P, Bianco C, Kessler D. Vox Sanguinis International Forum on donor notification and counselling strategies for markers of transfusion-transmissible infections. Vox Sang 2017; 112:e1-e21. [PMID: 28318012 DOI: 10.1111/vox.12508] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
| | | | - M Fearon
- Medical Microbiology, Canadian Blood Services, 67 College Street, Toronto, ON, Canada
| | - M Bigham
- Canadian Blood Services, 4750 Oak Street, Vancouver, BC, V6H 2N9, Canada
| | - R Djoudi
- Etablissement Français du Sang, 20, avenue du stade de France, 93218, La Plaine Saint Denis Paris, France
| | - P Gallian
- Etablissement Français du Sang, Qualification Biologique du Don, 149 Boulevard Baille, Marseille, 13005, France
| | - G Woimant
- Etablissement Français du Sang, Médecine, la Recherche et l'Innovation, La Plaine Saint-Denis Île-de-France, France
| | - C Lee
- Hong Kong Red Cross Blood Transfusion Service, 15, King's Park Rise, Kowloon Hong Kong, China
| | - J N S Leung
- Hong Kong Red Cross Blood Transfusion Service, Blood Collection and Donor Recruitment Department, 15 King's Park Rise, Kowloon, Hong Kong, China
| | - W C Tsoi
- Hong Kong Red Cross Blood Transfusion Service, Laboratory Department, 15 King's Park Rise, Kowloon Hong Kong, China
| | - N Marwaha
- Department of Transfusion Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India
| | - S Sachdev
- Department of Transfusion Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India
| | - K Tadokoro
- Japanese Red Cross Blood Service, 1-1-3 Shiba Daimon Minato-ku, Tokyo, 105-8521, Japan
| | - Y Tani
- Japanese Red Cross Osaka Blood Center, 2-4-43 Morinomiya Joto-ku, Osaka, 536-8505, Japan
| | - H Matsukura
- Japanase Red Cross Kinki Block Blood Center, 7-5-17 Saito Asagi, Ibaraki, 567-0085, Japan
| | -
- State Health Care Facility Sverdlovsk Regional Blood Transfusion Station, 8 Palmyro Tolyatti Street, Ekaterinburg, 620000, Russia
| | - N Shantseva
- Laboratory Diagnosis' Department, 7A, Lenin Street, Apt. 50, Pervouralsk, Sverdlovsk Reg, 623111, Russsia
| | - E Zhiburt
- Blood Transfusion Department, Pirogov National Medical Surgical Center, 70, Nizhnyaya Pervomayskaya ul., Moscow, 105203, Russia
| | - S Hindawi
- Blood Transfusion Services, King Abdulaziz University, PO Box 80215, Jeddah, 21589, Saudi Arabia
| | - J Chay
- Blood Services Group, Health Sciences Authority, 11 Outram Road, Singapore, 169078, Singapore
| | - T Huang
- Blood Services Group, Health Sciences Authority, 11 Outram Road, Singapore, 169078, Singapore
| | - D Teo
- Blood Services Group, 11 Outram Road, Singapore, 169078, Singapore
| | - N Moleli
- South African National Blood Service, 1 Constantia Boulevard, Constantia Kloof Ext 22, 1709, Gauteng, South Africa
| | - S Oyonarte
- Blood Transfusion Center, Seville, Spain
| | - S B A Jayasekara
- National Blood Centre, 555/5D, Elvitigala Mawatha, Narahenpita Colombo 05, Sri Lanka
| | - A Bokhorst
- Sanquin Blood Supply, 1066 CX, Amsterdam, The Netherlands
| | - P van den Burg
- Transfusion Medicine, Sanquin Blood Supply, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands
| | - P Hewitt
- NHS Blood and Transplant, London, UK
| | - C Bianco
- International Society of Blood Transfusion, 6524 Elgin Lane, Bethesda, MD, 20817, USA
| | - D Kessler
- New York Blood Center, 310 East 67th Street, New York, NY, 10065, USA
| |
Collapse
|
46
|
Sharma RR, Lozano M, Fearon M, Bigham M, Djoudi R, Gallian P, Woimant G, Lee C, Leung JNS, Tsoi WC, Marwaha N, Sachdev S, Tadokoro K, Tani Y, Matsukura H, Shantseva N, Zhiburt E, Hindawi S, Chay J, Huang T, Teo D, Moleli N, Oyonarte S, Jayasekara SBA, Bokhorst A, van den Burg P, Hewitt P, Bianco C, Kessler D. Vox Sanguinis International Forum on donor notification and counselling strategies for markers of transfusion-transmissible infections: summary. Vox Sang 2017; 112:388-396. [DOI: 10.1111/vox.12469] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- R. R. Sharma
- Department of Transfusion Medicine; Postgraduate Institute of Medical Education and Research; Sector 12 Chandigarh 160012 India
| | - M. Lozano
- Department of Hemotherapy and Hemostasis; University Clinic Hospital; Villaroel 170 Barcelona 08036 Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
García-Esperón C, Carrera D, Prats-Sánchez L, Lozano M, Escudero D. Focal leptomeningeal uptake, a new radiological finding in pseudomigraine with pleocytosis. Neurología (English Edition) 2017. [DOI: 10.1016/j.nrleng.2015.03.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
48
|
Rosenthal VD, Al-Abdely HM, El-Kholy AA, AlKhawaja SAA, Leblebicioglu H, Mehta Y, Rai V, Hung NV, Kanj SS, Salama MF, Salgado-Yepez E, Elahi N, Morfin Otero R, Apisarnthanarak A, De Carvalho BM, Ider BE, Fisher D, Buenaflor MCS, Petrov MM, Quesada-Mora AM, Zand F, Gurskis V, Anguseva T, Ikram A, Aguilar de Moros D, Duszynska W, Mejia N, Horhat FG, Belskiy V, Mioljevic V, Di Silvestre G, Furova K, Ramos-Ortiz GY, Gamar Elanbya MO, Satari HI, Gupta U, Dendane T, Raka L, Guanche-Garcell H, Hu B, Padgett D, Jayatilleke K, Ben Jaballah N, Apostolopoulou E, Prudencio Leon WE, Sepulveda-Chavez A, Telechea HM, Trotter A, Alvarez-Moreno C, Kushner-Davalos L, Desse J, Maurizi D, Montanini A, Chaparro G, Stagnaro J, Romani A, Bianchi A, Álvarez G, Palaoro A, Bernan M, Cabrera-Montesino R, Domínguez C, Rodríguez C, Silva C, Bogdanowicz E, Riera F, Benchetrit G, Perez I, Vimercati J, Marcos L, Ramasco L, Caridi M, Oyola M, Rodríguez M, Spadaro M, Olivieri M, Saul P, Juarez P, Pérez R, Botta P, Quintana D, Ríos A, Stagnaro J, Chediack V, Chilon W, Alsayegh AI, Yaseen FH, Hani LF, Sowar SF, Magray TA, Medeiros E, Alves De Oliveira A, Romario-Mendes A, Fernandes-Valente C, Santos C, Escudeiro D, Azevedo-Ferreira Lima D, Azevedo-Pereira D, Onzi-Siliprandi E, Serpa-Maia F, Aguiar-Leitao F, Assuncao-Ponte G, Dos Anjos-Lima J, Olszewski J, Harten Pinto Coelho K, Alves De Lima L, Mendonca M, Maciel-Canuto Amaral M, Tenorio M, Gerah S, Andrade-Oliveira-Reis M, Moreira M, Ximenes-Rocha Batista M, Campos-Uchoa R, Rocha-Vasconcelos Carneiro R, Amaral De Moraes R, Do Nascimento S, Moreira-Matos T, Lima-De Barros Araujo T, De Jesus Pinheiro-Bandeira T, Machado-Silva V, Santos Monteiro W, Hristozova E, Kostadinov E, Angelova K, Velinova V, Dicheva V, Guo X, Ye G, Li R, Song L, Liu K, Liu T, Song G, Wang C, Yang X, Yu H, Yang Y, Martínez A, Vargas-García A, Lagares-Guzmán A, González A, Linares C, Ávila-Acosta C, Santofimio D, Yepes-Gomez D, Marin-Tobar D, Mazo-Elorza D, Chapeta-Parada E, Camacho-Moreno G, Roncancio-Vill G, Valderrama-Marquez I, Ruiz-Gallardo J, Ospina-Martínez J, Osorio J, Marín-Uribe J, López J, Gualtero S, Rojas J, Gomez-Nieto K, Rincon L, Meneses-Ovallos L, Canas-Giraldo L, Burgos-Florez L, Amaral-Almeida Costa M, Rodriguez M, Barahona-Guzmán N, Mancera-Paez O, Rios-Arana P, Ortega R, Romero-Torres S, Pulido-Leon S, Valderrama S, Moreno-Mejia V, Raigoza-Martinez W, Villamil-Gomez W, Pardo-Lopez Y, Argüello-Ruiz A, Solano-Chinchilla A, Muñoz-Gutierrez G, Calvo-Hernández I, Maroto-Vargas L, Zuniga M, Valverde-Hernandez M, Chavarria-Ugalde O, Herrera B, Díaz C, Bovera M, Cevallos C, Pelaez C, Jara E, Delgado V, Coello-Gordon E, Picoita F, Guerrero-Toapant F, Valencia F, Santacruz G, Gonzalez H, Pazmino L, Garcia M, Arboleda M, Lascano M, Alquinga N, Ramírez V, Yousef RH, Moustafa AEM, Ahmed A, Elansary A, Ali AM, Hasanin A, Messih AA, Ramadan A, El Awady B, Hassan D, Abd El Aziz D, Hamza H, Agha HM, Ghazi IA, ElKholy J, Fattah MA, Elanany M, Mansour M, Haleim M, Fouda R, El-Sherif RH, Bekeit S, Bayani V, Elkholy Y, Abdelhamid Y, Salah Z, Rivera D, Chawla A, Manked A, Azim A, Mubarak A, Thakur A, Dharan A, Patil A, Sasidharan A, Bilolikar AK, Anirban Karmakar A, Mathew A, Kulkarni A, Agarwal A, Sriram A, Dwivedy A, Dasgupta A, Bhakta A, Suganya AR, Poojary A, Mani AK, Sakle A, Abraham BK, Padmini B, Ramachandran B, Ray B, Pati BK, Chaudhury BN, Mishra BM, Biswas S, Saibala MB, Jawadwala BQ, Rodrigues C, Modi C, Patel C, Khanna D, Devaprasad D, Divekar D, Aggarwal DG, Divatia J, Zala D, Pathrose E, Abubakar F, Chacko F, Gehlot G, Khanna G, Sale H, Roy I, Shelgaonkar J, Sorabjee J, Eappen J, Mathew J, Pal J, Varma K, Joshi KL, Sandhu K, Kelkar R, Ranganathan L, Pushparaj L, Lavate M, Latha M, Suryawanshi M, Bhattacharyya M, Kavathekar M, Agarwal MK, Patel M, Shah M, Sivakumar M, Kharbanda M, Bej M, Potdar M, Chakravarthy M, Karpagam M, Myatra S, Gita N, Rao N, Sen N, Ramakrishnan N, Jaggi N, Saini N, Pawar N, Modi N, Pandya N, Mohanty N, Thakkar P, Joshi P, Sahoo PK, Nair PK, Kumar PS, Patil P, Mukherjee P, Mathur P, Shah P, Sukanya R, Arjun R, Chawla R, Gopalakrishnan R, Venkataraman R, Raut S, Krupanandan R, Tejam R, Misra R, Debroy R, Saranya S, Narayanan S, Mishra S, Saseedharan S, Sengupta S, Patnaik S, Sinha S, Blessymole S, Rohra S, Rajagopal S, Mukherjee S, Sengupta S, John S, Bhattacharya S, Sijo, Bhattacharyya S, Singh S, Sohanlal T, Vadi S, Dalal S, Todi S, Kumar S, Kansal S, Misra S, Bhattacharyya S, Nirkhiwale S, Purkayastha SK, Mukherjee S, Singh S, Sahu S, Sharma S, Kumar S, Basu S, Shetty S, Shah S, Singhal T, Francis T, Anand T, Venkateshwar V, Thomas V, Kothari V, Velupandi, Kantroo V, Sitohang G, Kadarsih R, Sanaei A, Maghsudi B, Sabetian G, Masjedi M, Alebouyeh M, Sherafat SJ, Mohamed YK, Al Khamis A, Alsaadi AS, Al-Jarie AA, Mutwalli AH, Rillorta A, Thomas A, Kelany A, Manao A, Alamri DM, Santiago E, Cruzpero E, Sawan FA, Al Qasmah FA, Alabdaly H, Al-Dossary HA, Ahmed H, Roshdi H, Al-Alkami HY, Hanafi H, Ammari HE, Hani HMA, Asiri IAA, Mendoza JA, Philipose J, Selga JO, Kehkashan, Ghalilah KM, Redito LS, Josph L, Al-Alawi M, Al-Gethamy MM, Madco M, Manuel M, Girvan M, Aldalaton M, De Guzman M, Alkhamaly M, Masfar M, Karrar MAA, Al Azmi MM, Quisai ML, Torres MM, Al-Abdullah N, Tawfic NA, Elsayed N, Abdulkhalik NS, Bugis NA, Ariola NC, Gad N, Alghosn N, Tashkandi N, Zharani NA, De Vera P, Krishnan R, Al Shehri RH, Jaha RNA, Thomas R, Cresencia RL, Penuliar R, Lozada R, Al Qahtani S, Twfik S, Al Faraj SH, El-Sherbiny S, Alih SJB, Briones S, Bukhari SZ, Alotaibi TSA, Gopal U, Nair U, Abdulatif WA, Hussain WM, Demotica WM, Spahija G, Baftiu N, Gashi A, Omar AA, Mohamed A, Rebello F, Almousa HH, Abdo NM, George S, Khamis S, Thomas S, Ahmad Zaatari A, Anwar Al Souheil A, Ayash H, Zeid I, Tannous J, Zahreddine N, Ahmadieh R, Mahfouz T, Kardas T, Tanzi V, Kanafani Z, Hammoud Z, Dagys A, Grinkeviciute D, Kevalas R, Kondratas T, Petrovska M, Popovska K, Mitrev Z, Miteva ZB, Jankovska K, Guroska ST, Gan CS, Othman AA, Yusof AM, Abidin ASZ, Aziz FA, Weng FK, Zainol H, Bakar KBA, Lum LCS, Mansor M, Zaman MK, Jamaluddin MFH, Hasan MS, Rahman RA, Zaini RHM, Zhazali R, Sri Ponnampala SSL, Chuah SL, Shukeri WFWM, Hassan WNW, Yusoff WNW, Mat WRW, Cureno-Diaz M, Aguirre-Avalos G, Flores-Alvarado A, Cerero-Gudino A, Zamores-Pedroza A, Cano-Munoz B, Hernandez-Chena B, Carreon-Martinez C, Coronado-Magana H, Corona-Jimenez F, Rodriguez-Noriega E, Alcala-Martinez E, Gonzalez-Diaz E, Guerra-Infante F, Arteaga-Troncoso G, Martinez-Falcon G, Leon-Garnica G, Delgado-Aguirre H, Perez-Gomez H, Sosa-Gonzalez I, Galindo-Olmeda J, Ayala-Gaytan J, Rodriguez-Pacheco J, Zamorano-Flores L, Lopez-Pulgarin J, Miranda-Novales M, Ramírez M, Lopez-Hurtado M, Lozano M, Gomez M, Sanchez-Castuera M, Kasten-Monges M, Gonzalez-Martinez M, Sanchez-Vargas M, Culebro-Burguet M, Altuzar-Figueroa M, Mijangos-Mendez J, Ramires O, Espinosa O, De Leon-Escobedo R, Salas-Flores R, Ruiz-Rendon R, Petersen-Morfin S, Aguirre-Diaz S, Esparza-Ahumada S, Vega-Gonzalez S, Gaona-Flores V, Monroy-Colin V, Cruz-Rivera Z, Bat-Erdene A, Narankhuu B, Choijamts B, Tuvdennyam B, Batkhuu B, Chuluunchimeg K, Enkhtsetseg D, Batjargal G, Bayasgalan G, Dorj M, Mendsaikhan N, Baatar O, Suvderdene P, Baigalmaa S, Khajidmaa T, Begzjav T, Tsuyanga, Ariyasuren Z, Zeggwagh A, Berechid K, Abidi K, Madani N, Abouqal R, Koirala A, Giri R, Sainju S, Acharya SP, Ahmed A, Raza A, Parveen A, Sultan F, Khan M, Paul N, Daud N, Yusuf S, Nizamuddin S, Garcia-Mayorca E, Castaño E, Moreno-Castillo J, Ballinas-Aquino J, Lara L, Vargas M, Rojas-Bonilla M, Ramos S, Mapp T, De Iturrado V, La Hoz Vergara C, Linares-Calderon C, Moreno D, Ramirez E, Ramírez Wong F, Montenegro-Orrego G, Sandoval-Castillo H, Pichilingue-Chagray J, Mueras-Quevedo J, Aibar-Yaranga K, Castillo-Bravo L, Santivanez-Monge L, Mayorga-Espichan M, Rosario-Tueros M, Changano-Rodriguez M, Salazar-Ramirez N, Marquez-Mondalgo V, Tajanlangit ALN, Tamayo AS, Llames CMJP, Labro E, Dy AP, Fortin J, Bergosa L, Salvio L, Bermudez V, Sg-Buenaflor M, Trajano M, Mendoza M, Javellana O, Maglente R, Arreza-Galapia Y, Navoa-Ng J, Kubler A, Barteczko-Grajek B, Dragan B, Zurawska M, Mikaszewska-Sokolewicz M, Zielinska M, Ramos-Ortiz G, Florin-Rogobete A, Vlad CD, Muntean D, Sandesc D, Papurica M, Licker M, Bedreag OH, Popescu R, Grecu S, Dumitrascu V, Molkov A, Galishevskiy D, Furman M, Simic A, Lekic D, Ristic G, Eremija J, Kojovic J, Nikolic L, Bjelovic M, Lesnakova A, Hlinkova S, Gamar-Elanbya M, Supa N, Prasan P, Pimathai R, Wanitanukool S, Somabutr S, Ben-Jaballah N, Borgi A, Bouziri A, Dilek A, Oncul A, Kaya A, Demiroz AP, Gunduz A, Ozgultekin A, Inan A, Yalcin A, Ramazanoglu A, Engin A, Willke A, Meco BC, Aygun C, Bulut C, Uzun C, Becerik C, Hatipoglu CA, Guclu CY, Ozdemir D, Yildizdas D, Ugurcan D, Azak E, Guclu E, Yilmaz EM, Sebnem-Erdinc F, Sirmatel F, Ulger F, Sari F, Kizilates F, Usluer G, Ceylan G, Ersoz G, Kaya G, Ertem GT, Senol G, Agin H, Cabadak H, Yilmaz H, Sungurtekin H, Zengin H, Turgut H, Ozgunes I, Devrim I, Erdem I, Işcanlı IGE, Bakir MM, Geyik M, Oral M, Meric M, Cengiz M, Ozcelik M, Altindis M, Sunbul M, Elaldi N, Kuyucu N, Unal N, Oztoprak N, Yasar N, Erben N, Bayram N, Dursun O, Karabay O, Coskun O, Horoz OO, Turhan O, Sandal OS, Tekin R, Esen S, Erdogan SY, Unal S, Karacorlu S, Sen S, Sen S, Sacar S, Yarar V, Oruc Y, Sahip Y, Kaya Z, Philip A, Elhoufi A, Alrahma H, Sachez E, Perez F, Empaire G, Vidal H, Montes-Bravo L, Guzman Siritt M, Orozco N, Navarrete N, Ruiz Y, De Anez ZDG, Van Trang DT, Minh DQ, Co DX, Anh DPP, Thu LTA, Tuyet LTD, Nguyet LTT, Chau NU, Binh NG, Tien NP, Anh NQ, Hang PT, Hanh TTM, Hang TTT, Thu TA, Thoa VTH. International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module. Am J Infect Control 2016; 44:1495-1504. [PMID: 27742143 DOI: 10.1016/j.ajic.2016.08.007] [Citation(s) in RCA: 217] [Impact Index Per Article: 27.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2016] [Accepted: 08/29/2016] [Indexed: 02/07/2023]
Abstract
BACKGROUND We report the results of International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2010-December 2015 in 703 intensive care units (ICUs) in Latin America, Europe, Eastern Mediterranean, Southeast Asia, and Western Pacific. METHODS During the 6-year study period, using Centers for Disease Control and Prevention National Healthcare Safety Network (CDC-NHSN) definitions for device-associated health care-associated infection (DA-HAI), we collected prospective data from 861,284 patients hospitalized in INICC hospital ICUs for an aggregate of 3,506,562 days. RESULTS Although device use in INICC ICUs was similar to that reported from CDC-NHSN ICUs, DA-HAI rates were higher in the INICC ICUs: in the INICC medical-surgical ICUs, the pooled rate of central line-associated bloodstream infection, 4.1 per 1,000 central line-days, was nearly 5-fold higher than the 0.8 per 1,000 central line-days reported from comparable US ICUs, the overall rate of ventilator-associated pneumonia was also higher, 13.1 versus 0.9 per 1,000 ventilator-days, as was the rate of catheter-associated urinary tract infection, 5.07 versus 1.7 per 1,000 catheter-days. From blood cultures samples, frequencies of resistance of Pseudomonas isolates to amikacin (29.87% vs 10%) and to imipenem (44.3% vs 26.1%), and of Klebsiella pneumoniae isolates to ceftazidime (73.2% vs 28.8%) and to imipenem (43.27% vs 12.8%) were also higher in the INICC ICUs compared with CDC-NHSN ICUs. CONCLUSIONS Although DA-HAIs in INICC ICU patients continue to be higher than the rates reported in CDC-NSHN ICUs representing the developed world, we have observed a significant trend toward the reduction of DA-HAI rates in INICC ICUs as shown in each international report. It is INICC's main goal to continue facilitating education, training, and basic and cost-effective tools and resources, such as standardized forms and an online platform, to tackle this problem effectively and systematically.
Collapse
|
49
|
Goldman M, Magnussen K, Gorlin J, Lozano M, Speedy J, Keller A, Pink J, Leung JNS, Chu CCY, Lee CK, Faed J, Chay J, Tan HH, Teo D, Djoudi R, Woimant G, Fillet AM, Castrén J, Miflin G, Vandewalle GC, Compernolle V, Cardenas JM, Infanti L, Holbro A, Buser A, van den Hurk K, Yahalom VJ, Gendelman V, Shinar E, Eder AF, Steele WR, O'Neill EM, Kamel H, Vassallo R, Delage G, Lebrun A, Robillard P, Germain M, Gandhi M, West KA, Klein HG. International Forum regarding practices related to donor haemoglobin and iron. Vox Sang 2016; 111:449-455. [DOI: 10.1111/vox.12431] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- M. Goldman
- Medical Services and Innovation; Canadian Blood Services; Ottawa ON Canada
| | - K. Magnussen
- Clinical Immunology/Blood Centre; Copenhagen University Hospital; Hvidovre Denmark
| | - J. Gorlin
- Physician Services; Innovative Blood Centers; St. Paul MN USA
| | - M. Lozano
- Hospital Clinic; Department of Hemotherapy and Hemostasis; Barcelona Spain
| | - J. Speedy
- Australian Red Cross Blood Service; Adelaide South Australia Australia
| | - A. Keller
- Australian Red Cross; Perth Western Australia Australia
| | - J. Pink
- Australian Red Cross Blood Service; Stafford Queensland Australia
| | - J. N. S. Leung
- Blood Collection and Donor Recruitment Department; Hong Kong Red Cross Blood Transfusion Service; Kowloon Hong Kong
| | - C. C. Y. Chu
- Blood Collection and Donor Recruitment Department; Hong Kong Red Cross Blood Transfusion Service; Kowloon Hong Kong
| | - C.-K. Lee
- Blood Collection and Donor Recruitment Department; Hong Kong Red Cross Blood Transfusion Service; Kowloon Hong Kong
| | - J. Faed
- Otago Site, New Zealand Blood Service; Department of Haematology; University of Otago; Dunedin New Zealand
| | - J. Chay
- Blood Services Group; Health Sciences Authority; 11 Outram Road Singapore City 169078 Singapore
| | - H. H. Tan
- Blood Services Group; Health Sciences Authority; 11 Outram Road Singapore City 169078 Singapore
| | - D. Teo
- Centre for Transfusion Medicine; Singapore City Singapore
| | - R. Djoudi
- Qualification Biologique du Don; Etablissement Français du Sang; St. Denis France
| | - G. Woimant
- EFS, Médecine, la Recherche et l'Innovation; La Plaine Saint-Denis France
| | - A.-M. Fillet
- Medical Department; Etablisement Français du Sang; 20 Avenue du Stade de France La Plaine Saint-Denis 93218 France
| | - J. Castrén
- Medical Support in Blood Donation; Finnish Red Cross Blood Service; Kivihaantie 7 Helsinki FI-00310 Finland
| | - G. Miflin
- NHS Blood and Transplant; Watford UK
| | | | - V. Compernolle
- Blood Services; Belgian Red Cross; Ottergemsesteenweg 413 Ghent B-9000 Belgium
| | - J. M. Cardenas
- Tejidos Humanos; Centro Vasco de Transfusion y Tejidos Humanos; Labeaga s/n Galdakao 48960 Spain
| | - L. Infanti
- Blood Donation Center; Swiss Red Cross; Hebelstrasse 10 Basel CH-4031 Switzerland
| | - A. Holbro
- Blood Transfusion Centre; Swiss Red Cross; Hebelstrasse 10 Basel CH-4031 Switzerland
- Department of Hematology; University Hospital Basel; Basel Switzerland
| | - A. Buser
- Blood Transfusion Centre; Swiss Red Cross; Hebelstrasse 10 Basel CH-4031 Switzerland
- Department of Hematology; University Hospital Basel; Basel Switzerland
| | - K. van den Hurk
- Donor Studies; Sanquin Research; Plesmanlaan 125 Amsterdam 1066 CX The Netherlands
| | - V. J. Yahalom
- National Blood Services; Magen David Adom-National Blood Services; Ramat Gan 5262100 Israel
| | - V. Gendelman
- National Blood Services; Magen David Adom-National Blood Services; Ramat Gan 5262100 Israel
| | - E. Shinar
- National Blood Services; Magen David Adom-National Blood Services; Ramat Gan 5262100 Israel
| | - A. F. Eder
- Biomedical Headquarters; American Red Cross; 15601 Crabbs Branch Way Rockville MD 20855 USA
| | - W. R. Steele
- Transmissible Disease Department; American Red Cross; 15601 Crabbs Branch Way Rockville MD 20855 USA
| | - E. M. O'Neill
- National Headquarters; Biomedical Services; American Red Cross; 15601 Crabbs Branch Way Rockville MD 20855 USA
| | - H. Kamel
- Medical Affairs; Blood Systems, Inc.; 6210 E. Oak Street Scottsdale AZ 85257 USA
| | - R. Vassallo
- Blood Systems, Inc.; 6210 E. Oak Street Scottsdale AZ 85257 USA
| | - G. Delage
- Medical Affairs; Héma-Quebec; 4045 boul. Cote-Vertu, Ville Saint-Laurent Montreal QC Canada
| | - A. Lebrun
- Medical Affairs; Héma-Quebec; 4045 boul. Cote-Vertu, Ville Saint-Laurent Montreal QC Canada
| | - P. Robillard
- Medical Affairs; Héma-Quebec; 4045 boul. Cote-Vertu, Ville Saint-Laurent Montreal QC Canada
| | - M. Germain
- Medical Affairs; Héma-Quebec; 4045 boul. Cote-Vertu, Ville Saint-Laurent Montreal QC Canada
| | - M. Gandhi
- Laboratory of Medicine and Pathology; Mayo Clinic Minnesota; 200 1st Street SW Rochester MN 55905 USA
| | - K. A. West
- Department of Transfusion Medicine; National Institutes of Health Clinical Center; 10 Center Drive, Room 1N226 Bethesda MD 20892 USA
| | - H. G. Klein
- Department of Transfusion Medicine; National Institute of Health; Warren G. Magnuson Clinical Center; 10 Center Drive, Room IC711 Bethesda MD 20892 USA
| |
Collapse
|
50
|
Gelpi R, Cid J, Lozano M, Revuelta I, Sanchez-Escuredo A, Blasco M, de Souza E, Esforzado N, Torregrosa JV, Cofán F, Ricart MJ, Campistol JM, Oppenheimer F, Diekmann F. Desensitization in ABO-Incompatible Kidney Transplantation With Low ABO Iso-Agglutinin Titers. Transplant Proc 2016; 47:2340-3. [PMID: 26518921 DOI: 10.1016/j.transproceed.2015.08.021] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/09/2023]
Abstract
BACKGROUND In ABO-incompatible (ABOi) kidney transplantation (KT) with low iso-agglutinin (IG) titers (IGT), standard pre-conditioning treatment might be excessive. To try to answer this question, we evaluated the pre-conditioning requirements of a group of ABOi KT with low ABO IGT in our center. Our main objective was to assess desensitization requirements for ABOi KT with low IGT (<16) at Hospital Clinic of Barcelona from 2006 to 2014. METHODS A retrospective study of desensitization (rituximab and plasma exchange [PE]) requirements for ABOi KT with IGT <16 was conducted. RESULTS One and 5 years after KT, patient survival was 100%. Renal graft survival was 90% at 1 and 5 years after KT. Mean PE performed before KT was 1.7 (standard deviation [SD], 1.703); 50% of the patients did not receive PE after transplantation, 30% received 2 sessions of PE, and 20% received only 1. The average is 0.8 (SD, 0.91).Follow-up IG determinations remained with low titers (≤8/8). No rebounds of titers were observed during the first 4 to 6 months after transplantation. CONCLUSIONS Recipients with IGT ≤8 required none or only 1 PE session to reach acceptable titers (titers ≤4) to perform ABOi KT safely. This information is useful to assess the possibility of a minimized desensitization protocol in ABOi KT donors with low titers of IG to reduce adverse effects, reduce cost, and simplify pre-transplant logistics.
Collapse
Affiliation(s)
- R Gelpi
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - J Cid
- Apheresis Unit, Department of Hemotherapy and Hemostasis, Hospital Clinic, Barcelona, Catalonia, Spain
| | - M Lozano
- Apheresis Unit, Department of Hemotherapy and Hemostasis, Hospital Clinic, Barcelona, Catalonia, Spain
| | - I Revuelta
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - A Sanchez-Escuredo
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - M Blasco
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - E de Souza
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - N Esforzado
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - J V Torregrosa
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - F Cofán
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - M J Ricart
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - J M Campistol
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - F Oppenheimer
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - F Diekmann
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain.
| |
Collapse
|